C (2010-2018)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2018


+ Studies in 2000- 2009 List
* Studies in Pre-2000 List
>Information in Another Section

CACHEXIA + (Weight Loss from Toxic Cytokines Deranging Carbohydrate, Lipid and Protein Metabolism)
CAFFEINE and the ENDOCANNABINOID SYSTEM +
CANCER-ADENOCARCINOMA
>CANCER–ADRENAL CORTICAL (See 2000-2009 List)
>CANCER-ANGIOSARCOMA (See News Articles 2010-2018)
>CANCER–BASAL CELL CARCINOMA (See CANCER-SKIN)
CANCER-BLADDER/URETHRAL
CANCER-BONE +
CANCER-BREAST*+
CANCER-CERVICAL +
>CANCER–CHEMOTHERAPY (See CHEMOTHERAPY)
CANCER-CHOLANGIOCARCINOMA +
CANCER-COLON/COLORECTAL +
CANCER-ENDOMETRIAL +
>CANCER–EWING TUMORS (See 2000-2009 List and CANCER-PNET/PRIMITIVE NEUROECTODERMAL TUMOR +)
CANCER-GASTRIC*+
CANCER-GLIOMA/BRAIN CANCERS*+
CANCER-HEAD AND NECK +
CANCER-ID-1 GENE (This Gene Makes Several Types of Cancer [Triple Negative Breast Cancer, Glioblastomas, some Colon and Salivary Cancers] More Aggressive so They Spread Faster. CBD Deactivates the ID-1 Gene)
CANCER-KAPOSI’S SARCOMA +
CANCER-KIDNEY +
CANCER-LEUKEMIA*+
CANCER-LIVER +
CANCER-LUNG*+
CANCER-LYMPHOMA*+
CANCER-MELANOMA*+
>CANCER–MESOTHELIOMA (See News Articles)
CANCER-MYELOMA*+
CANCER-NASOPHARYNGEAL
CANCER-NEUROBLASTOMA*+
CANCER-ORAL*+
CANCER-OVARIAN +
CANCER-PANCREATIC +
CANCER-PITUITARY ADENOMA +
>CANCER-PNET/PRIMITIVE NEUROECTODERMAL TUMOR + (See News Articles 2010-2016)
CANCER-PROSTATE*+
CANCER-RHABDOMYOSARCOMA +
CANCER–SALIVARY GLAND
CANCER-SKIN +
CANCER-SQUAMOUS CELL CARCINOMA +
CANCER-TESTICULAR
top
CANCER-THYROID +
CANCER-VARIOUS/UNNAMED +
CANCER-VULVAR
CANNABINOID HYPEREMESIS SYNDROME + (Vomiting Due To Purported Cannabinoid ‘Overdose’ [Azadirachtin and/or PGR Poisoning])
>CARDIOVASCULAR (See HEART DISEASE)
CARPAL TUNNEL SYNDROME +
CATALEPSY (Bodily Condition Marked by Sudden Rigidity and Fixation of Posture)
CATATONIA
CELIAC DISEASE +
CEREBRAL PALSY*+
CHAGAS DISEASE/AMERICAN TRYPANOSOMIASIS
>CHARCOT-MARIE-TOOTH DISEASE (Inherited Neurological Disorder – See News Articles 2010-2016)
CHEMICAL COMPOSITION*+
CHEMICAL INTOLERANCE/CHEMICAL SENSITIVITY
CHEMOTHERAPY*+
CHEST PAIN-NON CARDIAC
CHILD ABUSE/NEGLECT
>CHILDHOOD IMMUNE THROMBOCYTOPENIA (See IMMUNE THROMBOCYTOPENIA)
CHILDREN*+ (2 to 12 Years Old, or Equivalent in Animals) NOTE: Children Do Not Always React to Cannabis Like Adults; They Can Experience Breathing Trouble and Other Serious Problems, Especially with High-Doses (Some Edibles, Hash, etc. See Also ADOLESCENTS and INFANTS)
CHOLERA*+
CHOLESTEROL*+
CHRONIC CEREBRAL HYPOPERFUSION (Long-Term Lack of Blood Getting to the Brain)
CHRONIC FATIGUE SYNDROME*
CHRONIC MOUNTAIN SICKNESS
CHRONIC TRAUMATIC ENCEPHALOPATHY/CTE (See Also BRAIN TRAUMA)
CIDS/CNS INJURY-INDUCED IMMUNODEFICIENCY SYNDROME
CIRCADIAN RHYTHM
CLINICAL ENDOCANNABINOID DEFICIENCY THEORY
CNS/CENTRAL NERVOUS SYSTEM
COCAINE and the ENDOCANNABINOID SYSTEM
>COGNITIVE EFFECTS (See IQ)
COHORT/LARGE STUDIES
COLITIS*+ (See Also BOWEL DISORDERS)
CONSTIPATION
COPD/CHRONIC OBSTRUCTIVE PULMONARY DISEASE*+
CORNEAL KERATITIS (Painful Sores or Ulcers on the Cornea of the Eye)
COUGH +
COWPOX (See Also SMALL POX)
CREATIVITY and CANNABIS
CRIME and CANNABIS
CROHN’S DISEASE*+ (See Also BOWEL DISORDERS)
CRPS/RSD-COMPLEX REGIONAL PAIN SYNDROME/REFLEX SYMPATHETIC DYSTROPHY/CAUSALGIA +
>CRUETZFELDT-JACOB DISEASE (See MAD COW DISEASE)
>CT-3 (See AJULMIC ACID in the SYNTHETICS Section)
CULTIVATION + (Not a ‘Grow Guide’, Just Interesting Stuff Found About Growing! [No Date Restriction])
CUSHING’S SYNDROME
CYSTIC FIBROSIS*+
CYSTITIS +
top


CACHEXIA 
Nutritional Interventions for Cancer-induced Cachexia (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106221/
The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22632862
Cannabinoids may be therapeutic in breast cancer (abst–2013)  http://resources.metapress.com/pdf-preview.axd?code=b831165531850165&size=largest
Clinical evaluation and optimal management of cancer cachexia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23953794
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Cannabis – therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats (full–2016) http://link.springer.com/article/10.1007%2Fs00213-016-4397-4
Sex Differences in Cannabinoid-Regulated Biology: A Focus on Energy Homeostasis  (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091302216300036
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome (abst–2016) http://link.springer.com/article/10.1007%2Fs40262-015-0363-2
Cachexia (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27883118

Clinical Evidence for Utilizing Cannabinoids in the Elderly (link to PDF–2017)  https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9-tetrahydrocannabinol, elicits hyperphagia in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28125508
Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with  advanced cancer? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29286357


CAFFEINE and the ENDOCANNABINOID SYSTEM +
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20087854
Combined effects of THC and caffeine on working memory in rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423236/
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory (full–2011) http://www.nature.com/npp/index.html
Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21330091
The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance (full–2013) http://www.nutritionandmetabolism.com/content/10/1/71
Management of non-alcoholic fatty liver disease in 2015 (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691699/
Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes.
(link to PDF – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25711828
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26099242
Connecting the dots, genome-wide association studies in substance use (article–2016)  https://www.researchgate.net/publication/298422234_Connecting_the_dots_genome-wide_association_studies_in_substance_use
Caffeine and Cannabis Effects on Vital Neurotransmitters and Enzymes in the Brain  Tissue of Juvenile Experimental Rats (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448447/
Chronic and acute adenosine A2A receptor blockade prevents long-term episodic  memory disruption caused by acute cannabinoid CB1 receptor activation (abst–2017) http://www.sciencedirect.com/science/article/pii/S0028390817300758
Pharmacological challenge studies with acute psychosocial stress (abst–2017)  http://www.psyneuen-journal.com/article/S0306-4530(17)30544-9/fulltext


CANCER-ADENOCARCINOMA
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23463621
Effect of anandamide on endometrial adenocarcinoma (Ishikawa) cell numbers: implications for endometrial cancer therapy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26312842
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells (full–2016) http://www.sciencedirect.com/science/article/pii/S2213231716301252
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10564&path%5B%5D=33384
Value of CNRIP1 promoter methylation in colorectal cancer screening and prognosis  assessment and its influence on the activity of cancer cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701694/
Endocannabinoids modulate apoptosis in endometriosis and adenomyosis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28549792
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in  those with pancreatic ductal adenocarcinoma (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28631495


CANCER-BLADDER/URETHRAL +
Functional role of cannabinoid receptors in urinary bladder (full-2010)  http://www.indianjurol.com/article.asp?issn=0970-1591;year=2010;volume=26;issue=1;spage=26;epage=35;aulast=Tyagi
TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20546877
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23416116
Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladder (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24652077
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression (abst–2014) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=118
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25623697
top

Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance (full–2016) https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-bpeer-reviewed-fulltext-article-OTT
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated
modifications of sphingolipids metabolism (full–2017)  http://www.nature.com/articles/srep42157
Systematic review of the potential role of cannabinoids as antiproliferative agents for
urological cancers (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/


CANCER-BONE +
Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931557/?toolubmed
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871326/
The endocannabinoid system and cancer: therapeutic implication (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical
hyperalgesia in a model of bone cancer pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104059/
Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21195743/abstract/Antinociceptive_effect_of_intrathecal_cannabinoid_receptor_agonist_WIN_55212_2_in_a_rat_bone_tumor_pain_model_
New targets, new drugs for metastatic bone pain: a new philosophy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21623686
Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21771590/abstract/Antinociceptive_effects_induced_through_the_stimulation_of_spinal_cannabinoid_type_2_receptors_in_chronically_inflamed_mice_
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339795/?toolubmed
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/jbmr.1732/full
Antimetastatic activity of honokiol in osteosarcoma (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/cncr.26434/full
Role of cannabinoid 2 receptor in the development of bone cancer pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22490961
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of Cfiber nociceptors in a murine model of cancer pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753184/
Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line (link to PDF–2013) http://www.dovepress.com/suppression-of-vascular-endothelial-growth-factor-expression-by-cannaba13597
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23518609
Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24008428
top
Involvement of PAR-4 in Cannabinoid-Dependent Sensitization of Osteosarcoma Cells to TRAIL-Induced Apoptosis (full–2014) http://www.ijbs.com/v10p0466.htm
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path%5B%5D=2233
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2 (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580018/
The secreted protein acidic and rich in cysteine is a critical mediator of cell death program induced by WIN/TRAIL combined treatment in osteosarcoma cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26698404
Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord (abst–2015) http://link.springer.com/article/10.1007/s10753-015-0168-3
A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935064 
Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27309350
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27993113
Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human
osteosarcoma (full–2017) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=17089&path%5B%5D=54691
Recent advances in understanding and managing cancer pain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482325/
Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral
type 2 cannabinoid receptor (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1043661816313809
Morin Suppresses Astrocyte Activation and Regulates Cytokine Release in Bone Cancer
Pain Rat Models (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28618070
Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer  (abst–2017) https://link.springer.com/article/10.1007%2Fs00210-017-1419-7
Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human
osteosarcoma (abst–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589594/


CANCER-BREAST*+
Anxiety Associated with Dying (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/666/
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917429/?tool=pmcentrez
A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931574/
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Rasfarnesylation mediate antitumor effects of anandamide in human breast cancer cells (full–2010) http://erc.endocrinology-journals.org/content/17/2/495.long
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) (full–2010) http://ijnp.oxfordjournals.org/content/13/7/905.long
Peripheral cannabinoid type 2 receptor regulates osteoclast formation, MDA-MB-231 breast cancer cell migration and bone marrow/tumour cell interaction via PI3 kinase/AKT and P38 pathways (abst–2010) http://www.thebonejournal.com/article/S8756-3282%2810%2901828-4/abstract
The endocannabinoid system and cancer: therapeutic implication (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full
Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion (full–2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168464/?tool=pubmed
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the crosstalk between apoptosis and autophagy (full–2011) http://mct.aacrjournals.org/content/10/7/1161.long
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis (full–2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410650/
The effect of CBD (BDS) botanical cannabinoid extraction on MCF-7 human breast carcinoma cells (abst–2011) http://eprints.hud.ac.uk/16197/ L-α-lysophosphatidylinositol meets GPR55: a deadly relationship (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21367464
L-α-lysophosphatidylinositol meets GPR55: a deadly relationship (abst–2011)  http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147(11)00013-7?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0165614711000137%3Fshowall%3Dtrue
Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20950604
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21995886
top
The CB2 receptor regulates osteoclast formation, breast cancer cell migration and osteoclast / tumour cell interaction via the PI3 Kinase/AKT pathway (abst–2011) http://www.thebonejournal.com/article/S8756-3282%2811%2900177-3/abstract
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/jbmr.1732/full
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells (full–2012) http://www.ejcancer.com/article/S0959-8049%2812%2900216-X/fulltext
Cannabinoids: A new hope for breast cancer therapy? (full-2012) http://www.bbm1.ucm.es/cannabis/archivos/publicaciones/Caffarel%20Cancer%20Treat%20Rev%202012%20online.pdf
Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/22553354
Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDAMB-231 breast cancer cell migration (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009504/
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis (full–2012) http://breast-cancer-research.com/content/14/1/R35
Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via
LKB1-dependent pathway and inhibits breast carcinogenesis (full – 2012)
https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-017-0829-2
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226396/
The effect of GWP42006, a cannabinoid extract on MCF-7 human breast carcinoma cells  (link to abst PDF–2012) http://eprints.hud.ac.uk/15130/
Id-1 gene and protein as novel therapeutic targets for metastatic cancer (abst–2012)
http://cancerres.aacrjournals.org/content/72/8_Supplement/5308.short?cited-by=yes;72/8_Supplement/5308
Induction of the fatty acid 2-hydroxylase (FA2H) gene by ∆9-tetrahydrocannabinol in human breast cancer cells (full–2013) https://www.jstage.jst.go.jp/article/jts/38/2/38_305/_pdf
Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells (full–2013) http://jpet.aspetjournals.org/content/early/2013/11/20/jpet.113.205120.long
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full–2013) http://www.hindawi.com/journals/ije/2013/259676/
The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827615/
Inhibition Of Fatty Acid Amide Hydrolase Activates Nrf2 Signaling And Induces Heme Oxygenase 1 Transcription In Breast Cancer Cells (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791989/
CB1 and CB2 Receptors are Novel Molecular Targets for Tamoxifen and 4OHTamoxifen (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860589/
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and
management (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706254/
US Patent Application 20130059018 – PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER (full–2013) http://www.google.com/patents/US20130059018
Cannabinoids may be therapeutic in breast cancer (article–2013)
http://resources.metapress.com/pdf-preview.axd?code=b831165531850165&size=largest
The effect of CBG (BDS) botanical cannabinoid extract on MCF-7 human breast carcinoma cells (abst–2013)  http://www.fasebj.org/content/27/1_Supplement/1105.21.short
Role of cannabinoid and vanilloid receptors in invasion of human breast carcinoma cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23394450
top
Magnolol induces apoptosis in MCF-7 human breast cancer cells through G2/M phase arrest and caspase-independent pathway (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24147344
Cannabinoids Control Breast Cancer Progression Through Id-1 (abst–2013)
http://grantome.com/grant/NIH/R01-CA135281-01A2
Inflammatory signaling as a therapeutic target for the treatment of breast cancer-induced bone pain (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/887.10?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Anandamide inhibits breast tumor-induced angiogenesis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140423/
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969077/
Magnolia dealbata seeds extract exert cytotoxic and chemopreventive effects on MDA-MB231 breast cancer cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24400594
Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209152/
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=2233
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast
cancer cells (link to PDF–2014) https://www.jstage.jst.go.jp/article/jts/39/5/39_711/_article
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling (download–2014) http://www.jbc.org/content/early/2014/07/02/jbc.M114.561761.full.pdf+html
Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer induced osteolysis (full–2015)  http://www.jbc.org/content/early/2015/07/20/jbc.M115.649608.long
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/ozojefv
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25660577
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against TripleNegative Breast Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25671648
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26254360
Curcumin sensitizes human U-87 glioblastoma and MCF-7 breast cancer cells to the endocannabinoid reuptake inhibitor OMDM-2 (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565733
Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent
Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in
Spinal Cord (abst–2015) http://link.springer.com/article/10.1007/s10753-015-0168-3
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent (full–2016) https://www.dovepress.com/modulation-of-breast-cancer-cell-viability-by-a-cannabinoid-receptor-2-peerreviewed-fulltext-article-BCTT Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=9408&path[]=29962
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path%5B%5D=9663&path%5B%5D=30267 Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10206&path%5B%5D=32116 Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00503/full
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0167240
Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26808012
Delineating the molecular mechanisms of tamoxifen’s oncolytic actions in estrogen receptor-negative cancers (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27083550 Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530354 Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27633508
top

Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and
Endocannabinoid System in Two Human Cancer Lines (full–2017)  http://www.arcmedres.com/article/S0188-4409(17)30026-7/fulltext
Regulation of Id-1 Gene Expression in Aggressive Breast Cancer and Glioblastoma Cells
Using Cannabinoid Compounds (link to PDF–2017) http://gssrr.org/index.php?journal=JournalOfBasicAndApplied&page=article&op=view&path%5B%5D=7621


CANCER-CERVICAL +
Marijuana Use is Not Associated with Cervical Human Papillomavirus Natural History or Cervical Neoplasia in HIV-Seropositive or HIV-Seronegative Women (full–2010) http://cebp.aacrjournals.org/content/19/3/869.full.pdf+html
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1 (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19914218
The evolving role of the endocannabinoid system in gynaecological cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958409
Over-expression of cannabinoid receptor 2 induces the apoptosis of cervical carcinoma Caski cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26062417
Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells (full–2016) http://bmccomplementalternmed.biomedcentral.com/articles/10.1186/s12906-016-1280-0


CANCER-CHOLANGIOCARCINOMA +
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872061/?toolubmed
Recent advances in the understanding of the role of the endocannabinoid system in liver diseases (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033442/
Recent advances in the regulation of cholangiocarcinoma growth (full–2010) http://ajpgi.physiology.org/content/299/1/G1.full
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: antiinvasion activity at low concentration and apoptosis induction at high concentration (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19916793
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21464819
The novel cannabinoid receptor GPR55, inhibits cholangiocarcinoma growth (abst–2011) http://www.fasebj.org/content/25/1_Supplement/1117.3.abstract?sid=c25fb29d-4fe2-4875-8a21-80afcada4527
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and
management (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706254/
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/


CANCER-COLON/COLORECTAL +
Effects of anandamide on polyamine levels and cell growth in human colon cancer cells (full–2010) http://ar.iiarjournals.org/content/30/7/2583.long
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids or the treatment of inflammatory diseases (full-2010) http://www.freepatentsonline.com/EP2044935A1.html
Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability (full-2010) http://jpet.aspetjournals.org/content/335/1/92.full
The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells (link to PDF-2010) http://www.spandidos-publications.com/ijo/37/1/187
Induction of p53-independent apoptosis by a novel synthetic hexahydrocannabinol analog is mediated via Sp1-dependent NSAID-activated gene-1 in colon cancer cells (abst-2010) http://www.sciencedirect.com/science/article/pii/S0006295210001735
top
Involvement of NSAID-activated gene-1 in a novel synthetic hexahydrocannabinol analogue-induced growth inhibition and apoptosis of colon cancer cells (abst-2010) http://www.fasebj.org/cgi/content/meeting_abstract/24/1_MeetingAbstracts/965.8?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=Hexahydrocannabinol&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa (full–2011) https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280884/
Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220322/
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14 (full–2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21412772
Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21575494
Honokiol in combination with radiation targets notch signaling to inhibit colon cancer
stem cells (full–2012) http://mct.aacrjournals.org/content/11/4/963.long
Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxiainducible factor-1α activation (full–2012) https://www.jstage.jst.go.jp/article/bpb/35/6/35_b12-00020/_pdf
The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model (full–2012) http://www.biomedcentral.com/content/pdf/2050-6511-13-S1-A23.pdf
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22231745
O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529923/
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576207/
The Cannabinoid WIN 55,212-2 Decreases Specificity Protein (Sp) Transcription Factors and the Oncogenic Cap Protein eIF4E in Colon Cancer Cells (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288937/
Honokiol as a Radiosensitizing Agent for Colorectal cancers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844429/
US Patent Application 20130059018 – PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER (full–2013) http://www.google.com/patents/US20130059018
Stabilization of MDA-7/IL-24 for colon cancer therapy (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23481022
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis derived non-psychotropic cannabinoid (full–2014)
http://carcin.oxfordjournals.org/content/35/12/2787.long
top
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells (link to PDF–2014) http://www.mdpi.com/1420-3049/19/1/1223
Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/24464350
WIN induces apoptotic cell death in human colon cancer cells through a block of  autophagic flux dependent on PPARγ down-regulation (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/24696378
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology (abst–2014)
http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary (Mo1121) Extravirgin olive oil up-regulates CB1 tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25533906
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high
content of cannabidiol (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0944711313004728
Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381706/
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/o229m7f
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25975960
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by
CB1 Receptor in Human Colon Cancer Cell Lines (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25893829
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408170
CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway (full – 2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=11968&path%5B%5D=37882
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26817719
Endocannabinoids in the gut (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27538961

The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561826
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23–IL-17 signalling in macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302499
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Dietary ω-3 Polyunsaturated Fatty Acids Inhibit Tumor Growth in Transgenic ApcMin/+
Mice, Correlating with CB1 Receptor Up-Regulation (full–2017)  http://www.mdpi.com/1422-0067/18/3/485/htm
Targeting cannabinoid receptors in gastrointestinal cancers for therapeutic uses: current
status and future perspectives (full–2017)  http://www.tandfonline.com/doi/full/10.1080/17474124.2017.1367663
Value of CNRIP1 promoter methylation in colorectal cancer screening and prognosis
assessment and its influence on the activity of cancer cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701694/
Fatty acid amide hydrolase (FAAH) inhibitor PF-3845 reduces viability, migration and
invasiveness of human colon adenocarcinoma Colo-205 cell line: an in vitro study (click “ABP” icon for download–2017) https://www.ncbi.nlm.nih.gov/pubmed/28850633
Pharmacological inhibition of MAGL lipase attenuates experimental colon  carcinogenesis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S104366181630932X
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in
addition to FOBT (abst–2017) http://link.springer.com/article/10.1007%2Fs11739-017-1610-3
Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and
Therapeutic Relevance (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28161834
G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects
to cannabinoid receptor 1 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28875496
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by
Rimonabant: a therapeutic target for colon cancer (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28916833
Cannabidiol and Palmitoylethanolamide are anti-inflammatory in the acutely inflamed
human colon (abst–2017)  http://www.clinsci.org/content/early/2017/09/26/CS20171288.long
Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon
Organoids (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758598/
Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29313885


CANCER-ENDOMETRIAL +
The Levels of the Endocannabinoid Receptor CB2 and Its Ligand 2-Arachidonoylglycerol Are Elevated in Endometrial Carcinoma (full–2010) http://endo.endojournals.org/content/151/3/921.full
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full–2013) http://www.hindawi.com/journals/ije/2013/259676/
Effect of anandamide on endometrial adenocarcinoma (Ishikawa) cell numbers: implications for endometrial cancer therapy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26312842
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10564&path%5B%5D=33384


CANCER-GASTRIC*+
Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and c onsequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958642/
Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20336665
top
Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21312237
Interactions between mu opioid receptor agonists and cannabinoid receptor agonists in
rhesus monkeys: antinociception, drug discrimination, and drug self-administration (link to download–2013) http://jpet.aspetjournals.org/content/early/2013/03/27/jpet.113.204099.long
Antineoplastic Effect of WIN 55,212-2, a Cannabinoid Agonist, in a Murine Xenograft Model of Gastric Cancer (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24335109
Simulation of Swanson’s Literature-Based Discovery: Anandamide Treatment Inhibits Growth of Gastric Cancer Cells In Vitro and In Silico (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100436
WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals (full–2016) http://www.karger.com/Article/FullText/447910
Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells (abst–2016) http://www.sciencedirect.com/science/article/pii/S0024320516305677
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Targeting cannabinoid receptors in gastrointestinal cancers for therapeutic uses: current
status and future perspectives (full–2017)  http://www.tandfonline.com/doi/full/10.1080/17474124.2017.1367663


CANCER-GLIOMA/BRAIN CANCERS*+
Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival (full-2010) http://mct.aacrjournals.org/content/9/1/180.full
The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806825/?tool=pubmed
Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835116/
Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919281/?tool=pubmed
Anti-tumoural effects of cannabinoid combinations – Patent TW201002315 (A) ―2010-01-16 (full-2010) http://worldwide.espacenet.com/publicationDetails/description?CC=TW&NR=201002315A&KC=A&FT=D&ND=3&date=20100116&DB=EPODOC&locale=en_EP
Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and AntiInflammatory Agents (full–2010) http://etd.uthsc.edu/WORLD-ACCESS/Gurley/2010-030-Gurley.pdf
Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20307616
A combined preclinical therapy of cannabinoids and temozolomide against glioma (full–2011) http://mct.aacrjournals.org/content/10/1/90.full
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131933/
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model (full-2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0018490
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14 (full-2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
top
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas-possible
role of Cannabis inhalation. (link to PDF–2011) http://cannabisclinicians.org/wp-content/uploads/2011/12/Cannabis-Inhalation-and-Brain-Tumor-Regression-2011.pdf
Cannabidiol inhibits angiogenesis by multiple mechanisms (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504989/
Alteration of endocannabinoid system in human gliomas (full-2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2011.07625.x/full
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents (full–2012)  http://carcin.oxfordjournals.org/content/34/1/48.long
Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells (full–2012) http://www.spandidospublications.com/or/28/4/1176;jsessionid=52ED17697BFDC92E6F5F848306023474?text=fulltext
The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients (abst–2012) http://link.springer.com/article/10.1007%2Fs12094-010-0604-7#page-1
Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22875710
Id-1 gene and protein as novel therapeutic targets for metastatic cancer (abst – 2012)
http://cancerres.aacrjournals.org/content/72/8_Supplement/5308.short?cited-by=yes;72/8_Supplement/5308
Id-1 is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594064/
Influence of serum and albumin on the in vitro anandamide cytotoxicity toward C6
glioma cells assessed by the MTT cell viability assay: implications for the methodology
of the MTT tests (full–2013) http://www.termedia.pl/Original-article-Influence-of-serum-and-albumin-on-the-in-vitro-anandamide-cytotoxicity-toward-C6-gliomacells-assessed-by-the-MTT-cell-viability-assay-implications-for-the-methodology-of-the-MTT-test,20,20493,1,1.html
Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813738/
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and
management (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706254/
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and
Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect (link to PDF–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076918
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076918
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054795
Cannabinoid signaling in glioma cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22879071
Regulation of cell proliferation by GPR55/cannabinoid receptors using (R,R’)-4’-methoxy-1-naphthylfenoterol in rat C6 glioma cell line (abst–2013) http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=695437a2 -7613-4bef-8697-2294df2da859&cKey=18ba6eb0-2c5f-4004-a56f-2d1f450e2ed1&mKey=9b2d28e7-24a0-466f-a3c9-07c21f6e9bc9
Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24142199/
Honokiol inhibits U87MG human glioblastoma cell invasion through endothelial cells by regulating membrane permeability and the epithelial-mesenchymal transition (full–2014) http://www.spandidospublications.com/ijo/44/1/187;jsessionid=D37A8D6D01845D28427059EB11FE132D?text=fulltext
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood Brain Barrier (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model (full-2014) http://mct.aacrjournals.org/content/13/12/2955.long
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Influence of serum and albumin on the in vitro anandamide cytotoxicity toward C6 glioma cells assessed by the MTT cell viability assay: implications for the methodology of the MTT tests (full–2013) http://www.termedia.pl/Original-article-Influence-of-serum-and-albumin-on-the-in-vitro-anandamidecytotoxicity-toward-C6-glioma-cells-assessed-by-the-MTT-cell-viability-assay-implications-for-themethodology-of-the-MTT-test,20,20493,1,1.html
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells (link to PDF–2014) http://www.mdpi.com/1420-3049/19/1/1223
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=2233
Anti-tumoural effects of cannabinoid combinations – US 8632825 B2 (full–2014)  https://www.google.com/patents/US8632825?dq=patent+cannabinoid&hl=en&sa=X&ei=M1DyU6KwDYHcOuy6gLgF&ved=0CDM
Q6AEwAw
The antitumor action of cannabinoids on glioma tumorigenesis (full–2014) http://www.hh.um.es/pdf/Vol_30/30_6/Zogopoulos-30-629-645-2015.pdf
top
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells (full–2015) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=3895&path%5B%5D=8966
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25590811
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/ozojefv
Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stemlike cells proliferation by inducing autophagy in a TRPV2-dependent manner (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25903924
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo (full–2015) http://www.spandidos-publications.com/10.3892/mmr.2015.4721
Co-mutated pathways analysis highlights the coordination mechanism in glioblastoma
multiforme (link to download–2015) http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=3797&category_id=109&keyword=cannabinoid&option=com_virtuemart&Itemid=1
On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26255146
Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26504004
Curcumin sensitizes human U-87 glioblastoma and MCF-7 breast cancer cells to the endocannabinoid reuptake inhibitor OMDM-2 (abst–2015) http://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565733
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance (full–2016) https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-bpeer-reviewed-fulltext-article-OTT
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via
autolysosome destabilization (full–2016)  http://www.tandfonline.com/doi/full/10.1080/15548627.2016.1213927
Influence of Biomechanical Properties and Cannabinoids on Tumor Invasion (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308229/
Anticancer mechanisms of cannabinoids (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade
gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may
indicate involvement of the endocannabinoid system (2016) (letter–2016)  http://link.springer.com/article/10.1007%2Fs00381-016-3333-6
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid
receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the
endocannabinoid system (abst–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3243-7
Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging
agents on the proliferation and viability of glioblastoma and neural progenitor cells in
culture (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27821713
Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and
Endocannabinoid System in Two Human Cancer Lines (full–2017)  http://www.arcmedres.com/article/S0188-4409(17)30026-7/fulltext
Regulation of human glioblastoma cell death by combined treatment of cannabidiol,
γ-radiation and small molecule inhibitors of cell signaling pathways (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650324/
Regulation of Id-1 Gene Expression in Aggressive Breast Cancer and Glioblastoma Cells
Using Cannabinoid Compounds (link to PDF–2017) http://gssrr.org/index.php?journal=JournalOfBasicAndApplied&page=article&op=view&path%5B%5D=7621
Hypoxia-induced inhibition of the endocannabinoid system in glioblastoma cells (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29130103
(±)-Sativamides A and B, Two Pairs of Racemic Nor-Lignanamide Enantiomers from the
Fruits of Cannabis sativa (abst–2018) https://pubs.acs.org/doi/10.1021/acs.joc.7b02765


CANCER-HEAD AND NECK +
Id-1 gene and protein as novel therapeutic targets for metastatic cancer (abst–2012)  http://cancerres.aacrjournals.org/content/72/8_Supplement/5308.short?cited-by=yes;72/8_Supplement/5308
Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24351902
The use of cannabinoids in chronic pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736518/
Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88- 2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23601830
Medical Marijuana Use in Patients With History of Head and Neck Squamous Cell
Carcinoma Treated With Radiation Therapy (abst–2014)  http://www.redjournal.org/article/S0360-3016(14)02729-1/fulltext
Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species (abst–2014) https://onlinelibrary.wiley.com/doi/10.1002/hed.23727/abstract
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26459312
Head and neck cancer among marijuana users: A meta-analysis of matched case-control studies (abst–2015) http://www.aobjournal.com/article/S0003-9969%2815%2930041-8/abstract
top
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanineinduced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells (full–2016) http://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2499-3
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27005465
Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is
correlated with metastasis to lymph nodes and distant organs, and poor prognosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27976824
Review: The Role of Cannabinoids on Esophageal Function—What We Know Thus Far  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665514/


CANCER-ID-1 GENE
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell
proliferation, invasion, and metastasis (full–2011)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410650/
Id-1 gene and protein as novel therapeutic targets for metastatic cancer (abst–2012)
http://cancerres.aacrjournals.org/content/72/8_Supplement/5308.short?cited-by=yes;72/8_Supplement/5308
Id-1 is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel
Therapeutic Target (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594064/
Cannabinoids Control Breast Cancer Progression Through Id-1 (abst–2013)  http://grantome.com/grant/NIH/R01-CA135281-01A2
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast
cancer cells (link to PDF–2014) https://www.jstage.jst.go.jp/article/jts/39/5/39_711/_article
Suppression of invasion and metastasis in aggressive salivary cancer cells through
targeted inhibition of ID1 gene expression (full – 2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883028/
Regulation of Id-1 Gene Expression in Aggressive Breast Cancer and Glioblastoma Cells
Using Cannabinoid Compounds (link to PDF – 2017)
http://gssrr.org/index.php?journal=JournalOfBasicAndApplied&page=article&op=view&path%5B%5D=7621


CANCER-KAPOSI’S SARCOMA +
Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcomaassociated herpesvirus-infected endothelium (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527984/


CANCER-KIDNEY 
Cannabinoid CB1 Receptor Is Downregulated in Clear Cell Renal Cell Carcinoma (full–2010) http://jhc.sagepub.com/content/58/12/1129.long
Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925659/
Cannabinoid CB(1) receptor is expressed in chromophobe renal cell carcinoma and renal oncocytoma (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23318578
Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24142157
The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: from nature to laboratory (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26654588
Overexpression of cannabinoid receptor 1 promotes renal cell carcinoma progression (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757850
Systematic review of the potential role of cannabinoids as antiproliferative agents for
urological cancers (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/
Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis
and progression (abst–2017) https://link.springer.com/article/10.1007%2Fs00432-017-2527-y


CANCER-LEUKEMIA*+
Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS) (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847847/?toolubmed
Cannabidiol induced a contrasting pro-apoptotic effect between freshly isolated and precultured human monocytes (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/20471992/abstract/Cannabidiol_induced_a_contrasting_pro_apoptotic_effect_between_freshly_isolated_and_precultured_human_monocytes_
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342927/
Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901602/
Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24123005
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells (link to PDF-2014) https://www.mdpi.com/1420-3049/19/1/1223
Effect of Honokiol on Proliferation and Apoptosis in HL-60 Cells and Its Potential Mechanism (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25543478
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study (full–2015) http://www.bbmt.org/article/S1083-8791(15)00375-4/fulltext
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot
study (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476410/
Downstream effects of endocannabinoid on blood cells: implications for health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957591
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns (full–2016)
http://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-2029-8
Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156693
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27237820
top
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Cannabidiol Reduces Leukemic Cell Size – But Is It Important? (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28392768
Metabolic gatekeeper function of B-lymphoid transcription factors (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621518/
Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can
be improved by altering the sequence of their administration (abst–2017)
https://www.spandidos-publications.com/10.3892/ijo.2017.4022


CANCER-LIVER +
The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis (full–2010) http://molpharm.aspetjournals.org/content/77/5/854.long
Recent advances in the understanding of the role of the endocannabinoid system in liver diseases (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033442/
The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20368112
Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20380798
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK dependent activation of autophagy (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131949/
Cannabinoid receptor activation correlates with the pro-apoptotic action of the β2-adrenergic agonist, (R,R’)-4-methoxy-1-naphthylfenoterol, in HepG2 hepatocarcinoma cells (full–2012) https://jpet.aspetjournals.org/content/early/2012/07/09/jpet.112.195206.long
Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells (full–2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439105/
Antimetastatic activity of honokiol in osteosarcoma (full-2012)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.26434/full
Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22946841
Evaluation of Anti-invasion Effect of Cannabinoids on Human Hepatocarcinoma Cells (abst-2012) https://www.ncbi.nlm.nih.gov/pubmed/22978792
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674350/
(R,R’)-4’-methoxy-1-naphthylfenoterol Inhibits GPR55 signaling and the modulation of motility in human cancer cells (abst–2013) http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=25370896-7d13-4f15-be76-f664d79b577d&cKey=87b7fec1-45cc-42b7-aca7-48c6b1d42773&mKey=9b2d28e7-24a0-466f-a3c9-07c21f6e9bc9
(R,R’)-4′-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization and Impairs Cancer Cell Motility (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24355564
PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24062073
Cannabisin B induces autophagic cell death by inhibiting the AKT/mTOR pathway and S
phase cell cycle arrest in HepG2 cells (abst–2013)  https://www.ncbi.nlm.nih.gov/pubmed/23411211
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells (full–2015) http://www.spandidos-publications.com/10.3892/mmr.2015.4477
[Corrigendum] Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells (correction–2015) http://www.spandidos-publications.com/mmr/13/1/1054
top

Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7950&path[]=23319
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979564/
Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis (full–2016) http://gut.bmj.com/content/65/10/1721.long
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Cannabinoid WIN55, 212-2 inhibits proliferation, invasion and migration of human
SMMC-7721 hepatocellular carcinoma cells (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27126940
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Cannabis use is associated with reduced prevalence of progressive stages of alcoholic
liver disease (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29341392


CANCER-LUNG*+
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025486/
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition  (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917429/?tool=pmcentrez
Does cannabis use predispose to chronic airflow obstruction? (full–2010)  http://erj.ersjournals.com/content/35/1/3.full?ijkey=d1405bb2fc0ed2aff675335858f284f7f470fbbc&keytype2=tf_ipsecsha
Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20668920
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1 (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19914218
Effects of smoking cannabis on lung function (full-2011) http://www.expert-reviews.com/doi/full/10.1586/ers.11.40
PAX3-FOXO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis (full–2011) http://cancerres.aacrjournals.org/content/71/24/7471.long
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1 (full–2011) http://www.fasebj.org/content/26/4/1535.long
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years (full–2012) http://jama.jamanetwork.com/article.aspx?articleid=1104848
Anti-proliferative and Anti-angiogenic Effects of CB2R Agonist (JWH-133) in Nonsmall Lung Cancer Cells (A549) and Human Umbilical Vein Endothelial Cells: an in Vitro Investigation (full–2012) http://fb.cuni.cz/file/5640/FB2012A0013.pdf
Antimetastatic activity of honokiol in osteosarcoma (full–2012)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.26434/full
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells (full–2013) http://mct.aacrjournals.org/content/12/1/69.long
Effects of marijuana smoking on the lung (full–2013) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201212-127FR#.U903xGN8E24
Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors (letter–2013)  http://www.jpsmjournal.com/article/S0885-3924%2813%2900115-2/fulltext
Magnolol induces apoptosis via caspase-independent pathways in non-small cell lung cancer cells (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23943503
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway (full–2014) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=1723&path%5B%5D=2142
Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/ijc.29036/full
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=2233
Cannabinoids inhibit angiogenic capacities of Endothelial cells via release of Tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24976505
CANNABINOIDS INCREASE LUNG CANCER CELL LYSIS BY LYMPHOKINEACTIVATED
KILLER CELLS VIA UPREGULATION OF ICAM-1 (abst–2014) http://www.sciencedirect.com/science/article/pii/S0006295214004201
top
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/ozojefv
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387115/
Human lung-resident macrophages express CB1 and CB2 receptors whose activation
inhibits the release of angiogenic and lymphangiogenic factors. (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787289/
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4 (full–2016) http://link.springer.com/article/10.1007/s00204-016-1664-4/fulltext.html
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7592&path[]=21964
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance (full–2016) https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-bpeer-reviewed-fulltext-article-OTT
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells (full–2016) http://www.sciencedirect.com/science/article/pii/S2213231716301252
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung
cancer by downregulation of EGFR pathway (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26741322
A Guide to the National Academy of Science Report on Cannabis: An Exclusive
Discussion with Panel Members (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569624/
Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609560/
The Fatty Acid Amide Hydrolase Inhibitor URB937 Ameliorates Radiation-Induced
Lung Injury in a Mouse Model (abst–2017)  http://link.springer.com/article/10.1007%2Fs10753-017-0568-7
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061818
Cannabis Use, Lung Cancer, and Related Issues (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29374567


CANCER-LYMPHOMA*+
WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223692/
The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22024769
The expression of the peripheral cannabinoid receptor CB2 has no effect on clinical outcome in diffuse large B-cell lymphomas (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21457344
Honokiol-induced apoptosis of human non-Hodgkin lymphoma Raji cells and its possible mechanism (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22126780
Expression and functional relevance of cannabinoid receptor 1 in hodgkin lymphoma (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081675
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path%5B%5D=2233
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278325/
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot
study (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476410/
Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26157624
top

The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751914/ High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana (full–2016) https://www.hindawi.com/journals/crit/2016/4028492/
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332


CANCER-MELANOMA*+
The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21807457
Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1) receptors: a keratinocyte-dependent effect (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21298280
The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action (full–2012) http://www.biomedcentral.com/1471-2407/12/92
Revisiting CB1 Receptor as Drug Target in Human Melanoma (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22447182
Cannabinoid receptor 2 is upregulated in melanoma (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23361273
Anticancer activity of anandamide in human cutaneous melanoma cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24041928
Calcium regulation by temperature-sensitive transient receptor potential channels in human uveal melanoma cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24084605
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
Docosahexaenoic acid, G protein-coupled receptors, and melanoma: is G protein-coupled receptor 40 a potential therapeutic target? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24576779
Honokiol inhibits melanoma stem cells by targeting notch signaling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25491779
Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25450590
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death (full–2015) http://www.nature.com/jid/journal/v135/n6/pdf/jid201545a.pdf
Differential role of cannabinoids in the pathogenesis of skin cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25921771
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25974027
Melanoma research in Hungary: promising results in a previously orphan tumor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26665186
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Standardized Cannabis sativa extract attenuates tau and stathmin gene expression in the
melanoma cell line (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673704/
Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating
p38 MAPK and p42/44 MAPK (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28601556
Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells (abst–2017) http://www.sciencedirect.com/science/article/pii/S0887233317300188


CANCER-MYELOMA
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy induced painful neuropathy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22229320
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2 (abst–2013) http://onlinelibrary.wiley.com/doi/10.1002/ijc.28591/abstract
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/mc.22251/abstract
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot
study (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476410/
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns (full–2016)
http://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-2029-8
top
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path%5B%5D=12721&path%5B%5D=40316 Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27237820
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27778331


CANCER-NASOPHARYNGEAL
Monoacylglycerol lipase promotes metastases in nasopharyngeal carcinoma (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128981/


CANCER-NEUROBLASTOMA*+
Cancer – Childhood neuroblastoma complete remission (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/667/
Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203169/?toolubmed
Dual inhibition of MAGL and type II topoisomerase by N-phenylmaleimides as a potential strategy to reduce neuroblastoma cell growth (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22127371
Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2′-deoxycytidine (abst–2012)
http://www.ncbi.nlm.nih.gov/pubmed/22262103
∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21603976
The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687660/
AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25460026
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells (abst–2015)
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791143/
JWH-133, a Selective Cannabinoid CB2 Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26842917
Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27054591
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in
human neuroblastoma cells (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0009308416301244
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061818


CANCER-ORAL*+
Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20516734
Cannabinoids attenuate cancer pain and proliferation in a mouse model (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099480/?toolubmed
Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells (full–2011) http://www.nature.com/ijos/journal/v3/n1/pdf/ijos20116a.pdf
Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: Recent advances and challenges (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22727410
Anti-proliferative effect of honokiol in oral squamous cancer through the regulation of specificity protein 1 (full–2013) http://www.spandidos-publications.com/ijo/43/4/1103?text=fulltext
Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24351902
Review of Various Herbal Supplements as Complementary Treatments for Oral Cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26863913
top


CANCER-OVARIAN +
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/20838378
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and
management (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706254/
Dronabinol Treatment of Refractory Nausea and Vomiting Related to Peritoneal Carcinomatosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24052427
Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24721263
The G-protein coupled receptor 55-agonist L-α-lysophosphatidylinositol mediates ovarian carcinoma cell induced angiogenesis (full–2015) http://www.actaps.com.cn/qikan/manage/wenzhang/2014-3-10.pdf
The therapeutic potential of orphan GPCRs, GPR35 and GPR55. (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
The evolving role of the endocannabinoid system in gynaecological cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958409
Why I chose to use cannabis (article–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791147/
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Cannabinoid Disposition After Human Intraperitoneal Use: An Insight Into
Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer (abst–2018)  http://www.clinicaltherapeutics.com/article/S0149-2918(17)31114-1/fulltext


CANCER-PANCREATIC +
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism (full–2011) http://www.nature.com/cddis/journal/v2/n4/pdf/cddis201136a.pdf
Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123370/
(R,R’)-4′-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization
and Impairs Cancer Cell Motility (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935314/
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells (full–2013) http://www.nature.com/cddis/journal/v4/n6/pdf/cddis2013151a.pdf
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23463621
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path%5B%5D=2233
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in
those with pancreatic ductal adenocarcinoma (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28631495


CANCER-PITUITARY ADENOMA +
R-flurbiprofen, a novel nonsteroidal anti-inflammatory drug, decreases cell proliferation and induces apoptosis in pituitary adenoma cells in vitro (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21938529
top


CANCER-PROSTATE*+
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930808/?toolubmed
The endocannabinoid system and cancer: therapeutic implication (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280884/
Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039283/
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20838378
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ―2011-09-14 (full–2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT&ND=&date=20110914&DB=&locale=en_EP
The endocannabinoid system in prostate cancer (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21912423
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21995886
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339795/?toolubmed
Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells (full–2012) http://endo.endojournals.org/content/153/1/29.full
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226396/
Towards the use of non-psychoactive cannabinoids for prostate cancer (download–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02121.x/pdf
Tumour epithelial expression levels of endocannabinoid markers modulates the value of endoglin-positive vascular density as a prognostic marker in prostate cancer (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23262399
Id-1 gene and protein as novel therapeutic targets for metastatic cancer (abst–2012)
http://cancerres.aacrjournals.org/content/72/8_Supplement/5308.short?cited-by=yes;72/8_Supplement/5308
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: proapoptotic effects and underlying mechanisms (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0065798
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full–2013) http://www.hindawi.com/journals/ije/2013/259676/
Distribution and Possible Function of Cannabinoid Receptor Subtype 1 in the Human
Prostate*—An Inhibitory Role for Growth in the Human Prostate Cancer (full–2013) http://file.scirp.org/Html/12-5000121_31406.htm
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and
management (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706254/
US Patent Application 20130059018 – PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER (full–2013) http://www.google.com/patents/US20130059018
top

Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity (abst–2013) http://www.sciencedirect.com/science/article/pii/S0223523413006247
The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109781/
Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900727/
Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145668/
Honokiol inhibits androgen receptor activity in prostate cancer cells (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946953/
In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines  (full–2014) http://file.scirp.org/Html/5-2500510_47691.htm
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path%5B%5D=2233
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25001513
Proapoptotic effect of endocannabinoids in prostate cancer cells (link to PDF–2015) http://www.spandidos-publications.com/10.3892/or.2015.3746
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/nlaavnr
Co-Localization of Alpha1-Adrenoceptors and GPR55: A Novel Prostate Cancer Paradigm? (full–2015) http://file.scirp.org/Html/2-2500616_55349.htm
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor
agonists with anticancer and immuno-modulatory activity (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0223523415002937
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26254360
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells (full–2016) http://www.nature.com/pcan/journal/vaop/ncurrent/full/pcan201619a.html
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/ 
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the
treatment of breast and prostate carcinomas (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27633508
A quantitative study on splice variants of N-acylethanolamine acid amidase in human
prostate cancer cells and other cells (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1388198116302645
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid
anandamide in prostate cancer cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599064/
Systematic review of the potential role of cannabinoids as antiproliferative agents for
urological cancers (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/


CANCER-RHABDOMYOSARCOMA +
PAX3-FOXO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis (full–2011) http://cancerres.aacrjournals.org/content/71/24/7471.long


CANCER–SALIVARY GLAND
Suppression of invasion and metastasis in aggressive salivary cancer cells through targeted inhibition of ID1 gene expression (abst–2016) http://www.cancerletters.info/article/S0304-3835%2816%2930256-7/abstract


CANCER-SKIN +
Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation (full–2010) http://carcin.oxfordjournals.org/content/31/11/2004.long
The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action (full–2012) http://www.biomedcentral.com/1471-2407/12/92
Chemopreventive effects of combination of honokiol and magnolol with α-santalol on skin cancer developments (full–2013) http://www.ddtjournal.com/action/downloaddoc.php?docid=687
top

Cyclooxygenase-2 regulates anandamide-induced endoplasmic reticulum stress in tumorigenic keratinocytes (abst–2013) http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=47d150a2-0c18-41e2-aeebccb249909524&cKey=7e13a39d-b13e-4de7-a0c8-179c2d78ec62&mKey=9b2d28e7-24a0-466f-a3c9-07c21f6e9bc9
Structure-dependent inhibitory effects of synthetic cannabinoids against 12-Otetradecanoylphorbol-13-acetate-induced inflammation and skin tumour promotion in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23837590
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path%5B%5D=2233
The effect of CBD, CBG and a combination of CBD plus CBG on Haccat human skin carcinoma cells (abst–2014) http://www.fasebj.org/content/28/1_Supplement/1048.19.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/mc.22257/full
Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26513129
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation (abs–2016) http://www.sciencedirect.com/science/article/pii/S0923181115300761


CANCER-SQUAMOUS CELL CARCINOMA +
Expression of cannabinoid receptor 2 in squamous cell carcinoma (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20335147
Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells (full–2011) http://www.nature.com/ijos/journal/v3/n1/pdf/ijos20116a.pdf
Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: Recent advances and challenges (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22727410
Anti-proliferative effect of honokiol in oral squamous cancer through the regulation of
specificity protein 1 (full–2013) http://www.spandidos-publications.com/ijo/43/4/1103?text=fulltext
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23601830
Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/hed.23727/abstract
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25001513
Medical Marijuana Use in Patients With History of Head and Neck Squamous Cell
Carcinoma Treated With Radiation Therapy (abst–2014)
http://www.redjournal.org/article/S0360-3016(14)02729-1/fulltext
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26459312
top

5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanineinduced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells (full–2016) http://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2499-3
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells (full–2016) http://www.sciencedirect.com/science/article/pii/S2213231716301252
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27005465 Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is correlated with metastasis to lymph nodes and distant organs, and poor prognosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27976824
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report (article–2017) http://www.jpsmjournal.com/article/S0885-3924(16)30328-1/abstract


CANCER–TESTICULAR
Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642772/
Systematic review of the potential role of cannabinoids as antiproliferative agents for
urological cancers (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061818


CANCER-THYROID +
Repositioning therapy for thyroid cancer: new insights on established medications (full–2014) http://erc.endocrinology-journals.org/content/21/3/R183.long
Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619873/
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/


CANCER-VARIOUS/UNNAMED +
Antitumorigenic Effects of Cannabinoids beyond Apoptosis (full-2010) http://jpet.aspetjournals.org/content/332/2/336.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain (full-2010) http://www.jpsmjournal.com/article/S0885-3924%2809%2900787-8/fulltext
Nutritional Interventions for Cancer-induced Cachexia (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106221/
NEW USE FOR CANNABINOID-CONTAINING PLANT EXTRACTS Patent application number: 20100249223 (full-2010) http://www.faqs.org/patents/app/20100249223
US Patent Application 20100204312 – METHODS AND COMPOSITIONS FOR TREATING CANCER (full-2010) https://www.google.com/patents/US20100204312
Targeting the Endocannabinoid System for the Treatment of Cancer – A Practical View (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20370711?dopt=Abstract
Cannabis-derived substances in cancer therapy–an emerging anti-inflammatory role for the cannabinoids (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20925645
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1 (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19914218
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/pdf/bph0163-1479.pdf
Intrathecal Administration of the Cannabinoid 2 Receptor Agonist JWH015 Can Attenuate Cancer Pain and Decrease mRNA Expression of the 2B Subunit of N-Methyld-Aspartic Acid (full–2011) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2011/08000/Intrathecal_Administration_of_the_Cannabinoid_2.33.aspx
top

The endocannabinoid system and cancer: therapeutic implication (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full–2011) http://annonc.oxfordjournals.org/content/22/9/2086.long
The intersection between cannabis and cancer in the United States (full–2011) http://www.croh-online.com/article/S1040-8428(11)00231-9/fulltext
Phytocannabinoids for use in the treatment of cancer – Patent GB2478595 (A) ― 2011-09-14 (full–2011) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT=D&ND=&date=20110914&DB=&locale=en_EP
Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134573/pdf/nihms275514.pdf
Update on the endocannabinoid system as an anticancer target (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21244344
The endocannabinoid system in the cancer therapy: an overview (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21428888
Cannabidiol inhibits angiogenesis by multiple mechanisms (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504989/
Cannabinoid-associated cell death mechanisms in tumor models (Review) (full–2012) http://www.spandidos-publications.com/ijo/41/2/407
Monoacylglycerol lipase – a target for drug development? (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01950.x/pdf
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth (full–2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226396/
Antimetastatic activity of honokiol in osteosarcoma (full–2012)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.26434/full
Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent
Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer (full–2012)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924623/
Off-Target Cannabinoid Effects Mediated by GPR55 (full–2012)  https://www.karger.com/Article/FullText/336872
Monoacylglycerol lipase – a target for drug development? (download – 2012)
http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01950.x/pdf
Role of Lipid Rafts/Caveolae in the Anticancer Effect of Endocannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22625418
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial (abst-2012) http://www.sciencedirect.com/science/article/pii/S1526590012000193
The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22632862
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22580111
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23103355
Towards the use of cannabinoids as antitumour agents (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22555283
Id-1 gene and protein as novel therapeutic targets for metastatic cancer (abst–2012)  http://cancerres.aacrjournals.org/content/72/8_Supplement/5308.short?cited-by=yes;72/8_Supplement/5308
Modulating the endocannabinoid system in human health and disease: successes and failures (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/febs.12260/pdf
Autophagy triggered by magnolol derivative negatively regulates angiogenesis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920944/
Harnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesis (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/febs.12473/full
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877544/
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
An open-label extension study to investigate the long-term safety and tolerability of THC / CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics (full–2013) http://www.jpsmjournal.com/article/S0885-3924%2812%2900439-3/fulltext
top

A potential role for GPR55 in gastrointestinal functions (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660623/
Therapeutic potential of monoacylglycerol lipase inhibitors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594462/
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full–2013) http://www.hindawi.com/journals/ije/2013/259676/
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706254/
The endocannabinoid signaling system in cancer. (full – 2013)
http://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(13)00044-8
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care (full–2013) http://cannabisclinicians.org/wp-content/uploads/2013/09/Med-Nec-for-Cannabis-in-Cancer-Israel.pdf
Cannabidiol as potential anticancer drug (download–2013)  http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04298.x/pdf
Critical appraisal of the potential use of cannabinoids in cancer management (link to PDF–2013) http://www.dovepress.com/critical-appraisal-of-the-potential-use-of-cannabinoids-in-cancer-mana-a14216
Endocannabinoid signaling in cancer: a rather complex puzzle (letter-2013) http://www.cell.com/trends/pharmacologicalsciences//retrieve/pii/S016561471300117X?_returnURL=http://linkinghub.elsevier.com/retrieve/pii/S016561471300117X?showall=true
The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors (letter–2013) http://www.jpsmjournal.com/article/S0885-3924%2813%2900115-2/fulltext
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23552853
The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23567453
Cytotoxic effect of Efavirenz is selective against cancer cells and associated with the cannabinoid system (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23612009
Preparation and characterization of Δ9-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23773072
Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1 (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23494106
Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24088353
Systematic review of the literature on clinical and experimental trials on the antitumor
effects of cannabinoids in gliomas (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24142199
Medical marijuana for cancer (full–2014) http://onlinelibrary.wiley.com/doi/10.3322/caac.21260/full
Marijuana and Body Weight (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204468/
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
top

Clinical evaluation and optimal management of cancer cachexia (full–2014) http://www.croh-online.com/article/S1040-8428%2813%2900166-2/fulltext
Target-Selective Phototherapy Using a Ligand-Based Photosensitizer for Type 2 Cannabinoid Receptor (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989837/
The Neurobiology of Cancer Pain (full–2014) http://journals.sagepub.com/doi/full/10.1177/1073858414525828
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling (full–2014) http://www.jbc.org/content/early/2014/07/02/jbc.M114.561761.full.pdf+html
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=2233
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases (link to upload-2014) http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (link to PDF–2014) http://www.degruyter.com/view/j/cmble.2014.19.issue-3/s11658-014-0200-x/s11658-014-0200-x.xml
Report on Medical Cannabis Research History- What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Is the Clinical Use of Cannabis by Oncology Patients Advisable? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24606496
The Role of Monoacylglycerol Lipase (MAGL) in the Cancer Progress (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24633487
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
Cannabinoid CB2 Receptor as a New Phototherapy Target for Inhibition of Tumor Growth (abst–2014) http://pubs.acs.org/doi/abs/10.1021/mp5001923
Characterization of HU-331 as a cannabinoid quinone inhibitor of topoisomerase II (abst–2014) http://www.fasebj.org/content/28/1_Supplement/549.6.abstract?sid=db987fd0 -3ef0-4796-aff6-4103f0c84daf
AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25460026
Use and medicalization of marihuana in cancer patients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25508539
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
The use of cannabinoids as anticancer agents (full–2015) http://www.sciencedirect.com/science/article/pii/S0278584615001190
Plant derived substances with anti-cancer activity: from folklore to practice (full–2015) http://journal.frontiersin.org/article/10.3389/fpls.2015.00799/full
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
top

Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy (full–2015) http://www.hindawi.com/journals/bmri/2015/506327/
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/pe7eb73
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25660577
The evolving role of the endocannabinoid system in gynaecological cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958409
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (abst–2015) http://www.sciencedirect.com/science/article/pii/S0885392414003121
Δ9 Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8 (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25713087
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the
Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo (full–2015) http://www.jimmunol.org/content/194/11/5211.long
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2 (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580018/
Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo (link to PDF–2015) http://www.spandidos-publications.com/10.3892/mmr.2015.4721
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science (interview-2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lestergrinspoon/
New insights into antimetastatic and antiangiogenic effects of cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25619715
Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/mc.22257/full
Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863017
Downstream effects of endocannabinoid on blood cells: implications for health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957591
Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179998
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26254360
A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26162535
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
Endocannabinoids and Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408171
Oncosuppressive functions of tribbles pseudokinase 3 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26517935
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26720619
Cannabinoid-induced autophagy: protective or death role? (abst–2015) http://www.sciencedirect.com/science/article/pii/S109888231530023X
Delta(9)-tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25669486
top

Cannabis and cancer: reality or pipe dream? (abst–2015) http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2815%2900302-2/abstract
Use of medical cannabis to reduce pain and improve quality of life in cancer patients  (abst–2015) http://meetinglibrary.asco.org/content/155674-165
Natural product modulators of transient receptor potential (TRP) channels as potential anti-cancer agents (full–2016) http://pubs.rsc.org/en/content/articlehtml/2016/cs/c5cs00916b
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7592&path[]=21964
Cannabis and cancer: toward a new understanding (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791146/
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Anticancer mechanisms of cannabinoids (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance (full–2016) https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-bpeer-reviewed-fulltext-article-OTT
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization (full–2016) http://www.tandfonline.com/doi/full/10.1080/15548627.2016.1213927
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00503/full
β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and
analgesic properties (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083753/
Influence of Biomechanical Properties and Cannabinoids on Tumor Invasion (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308229/
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine
Receptor and Cannabinoid Receptor 2 (CB2) Reveal a Mechanism for Regulation of
Tumor Progression (download–2016)  http://www.jbc.org/content/early/2016/02/03/jbc.M115.712661.long
Using Medical Cannabis in an Oncology Practice (article–2016)  http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncology-practice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Cannabis and Cannabinoids (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2592497
Ligands for cannabinoid receptors, promising anticancer agents (abst–2016) http://www.sciencedirect.com/science/article/pii/S0024320515301521
Role of the lysophosphatidylinositol/GPR55 axis in cancer (abst–2016) http://www.sciencedirect.com/science/article/pii/S2212492615300105
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome (abst–2016) http://link.springer.com/article/10.1007%2Fs40262-015-0363-2
Antitumorigenic targets of cannabinoids – current status and implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27070944
Delineating the molecular mechanisms of tamoxifen’s oncolytic actions in estrogen receptor-negative cancers (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27083550
The Use of Medical Marijuana in Cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215434
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530738
N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27760835
Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review) (abst–2016) https://www.spandidos-publications.com/10.3892/ijmm.2016.2779
Bioactive spirans and other constituents from the leaves of Cannabis sativa f. sativa (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27848262
State of the evidence: Cannabinoids and cancer pain-A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27863159
Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27420392
Cannabinoids – a new weapon against cancer? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28100841
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)
https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)
https://www.ncbi.nlm.nih.gov/books/NBK65755/
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives (full–2017)
http://meetinglibrary.asco.org/record/140727/edbook#fulltext
Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and
Endocannabinoid System in Two Human Cancer Lines (full–2017)
http://www.arcmedres.com/article/S0188-4409(17)30026-7/fulltext
Recent advances in understanding and managing cancer pain (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482325/
Targeting cannabinoid receptors in gastrointestinal cancers for therapeutic uses: current
status and future perspectives (full–2017)
http://www.tandfonline.com/doi/full/10.1080/17474124.2017.1367663
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and
Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
A Guide to the National Academy of Science Report on Cannabis: An Exclusive
Discussion with Panel Members (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569624/
Cannabis use among patients at a comprehensive cancer center in a state with legalized
medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Systematic review of the potential role of cannabinoids as antiproliferative agents for
urological cancers (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation
and Pain (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the
intestinal lymphatic system and prominent immunomodulation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674070/
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions,
Possibilities, and Challenges (full–2017)  https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full
A selective review of medical cannabis in cancer pain management (link to download–2017) http://apm.amegroups.com/article/view/16199/16359
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
The Role of Cannabinoids in the Treatment of Cancer in Pediatric Patients (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4044
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report (article–2017)  http://www.jpsmjournal.com/article/S0885-3924(16)30328-1/abstract
Cannabis Guidelines (article–2017) https://cjon.ons.org/cjon/21/4/cannabis-guidelines
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured
interview study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28040884
Cannabidiol: State of the art and new challenges for therapeutic applications (abst–2017) http://www.sciencedirect.com/science/article/pii/S0163725817300657
Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28425013
Gαs signalling of the CB1 receptor and the influence of receptor number (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28516479
Analysis of Natural Product Regulation of Cannabinoid Receptors in the treatment of
Human Disease (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0163725817301511
A Review of the Therapeutic Antitumor Potential of Cannabinoids (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28799775
Cannabinoids as Anticancer Drugs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826542
Cannabidiol, a novel inverse agonist for GPR12 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28888984
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols
Oromucosal Spray as Adjunctive Therapy in Advanced Cancer Patients With Chronic
Uncontrolled Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28923526
Synergistic interaction of the cannabinoid and death receptor systems: A potential target
for future cancer therapies? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28948607
Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29053063
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor Independent Mechanisms (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29066974
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061818
Current evidence of cannabinoid-based analgesia obtained in preclinical and human
experimental settings (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29160600
Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with
advanced cancer? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29286357
The role of cannabinoids in pain control: the good, the bad, and the ugly (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29338150
Medical Cannabis: The Oncology Nurse’s Role in Patient Education About the Effects of
Marijuana on Cancer Palliation (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29350699
Targeting the endocannabinoid system as a potential anticancer approach (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29390896


CANCER-VULVAR
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/


CANNABINOID HYPEREMESIS SYNDROME +
Cannabinoid hyperemesis. (# 1) (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886568/?toolubmed
Cannabinoid Hyperemesis and Compulsive Bathing: A Case Series and Paradoxical Pathophysiological Explanation (full–2010) http://www.jabfm.org/content/23/6/790.long
Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms (link to PDF–2010) http://www.mdpi.com/1424-8247/3/7/2163/
The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20130993
A man in his 30s with recurrent vomiting and abdominal pain relieved by hot showers (full–2011) http://tidsskriftet.no/article/2167144/en_GB/
Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21464265
Cannabis Hyperemesis Syndrome (# 1) (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21692016
Cannabis Hyperemesis Syndrome (# 2) (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/
Image of the month. Skin discoloration from compulsive bathing in a patient with hyperemesis syndrome (full–2011) http://www.cghjournal.org/article/S1542-3565%2810%2900843-8/fulltext
Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21877303
Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21886087
Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21170540
Pediatric cannabinoid hyperemesis: two cases (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21131803
Hyperemesis and a High Water Bill (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22069047
Cannabinoid hyperemesis syndrome: case report of a paradoxical reaction with heavy marijuana use (full–2012) http://www.hindawi.com/journals/crim/2012/757696/
top

Cannabinoid hyperemesis: a case series of 98 patients (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22305024
Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21951771
Cannabis—A Valuable Drug That Deserves Better Treatment (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498425/
Cannabinoid hyperemesis. (# 2) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22186263
A hot bath to calm what ails you – the Cannabis Hyperemesis Syndrome (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22423343
Cannabinoid Hyperemesis Syndrome: A Case Series and Review of Previous Reports (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22480624
Spicing Up the Differential for Cyclic Vomiting: A Case of Synthetic-Cannabinoid Induced Hyperemesis Syndrome (CH) (abst–2012) http://d2j7fjepcxuj0a.cloudfront.net/wp-content/uploads/2012/10/ACG2012_Poster83.pdf
Cannabinoid Hyperemesis Syndrome (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847982/
Compulsive showering and marijuana use – the cannabis hyperemisis syndrome (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757911/
Cannabinoid Hyper-emesis Syndrome: An Enigma (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24379506
Cannabinoid hyperemesis syndrome with extreme hydrophilia (link to PDF–2013) http://www.dovepress.com/cannabinoid-hyperemesis-syndrome-with-extreme-hydrophilia-a14072
Haloperidol for treatment of cannabinoid hyperemesis syndrome (1st page–2013)
http://www.ajemjournal.com/article/S0735-6757%2813%2900126-5/abstract
Cannabinoid hyperemesis acute renal failure: a common sequela of cannabinoid
hyperemesis syndrome (1st page–2013) http://www.ajemjournal.com/article/S0735-6757%2813%2900850-4/abstract
A Case of Cannabinoid Hyperemesis Syndrome Caused by Synthetic Cannabinoids (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23890687
A Gut Gone to Pot: A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid (full–2014) http://www.hindawi.com/journals/criem/2014/167098/
Mid-ventricular Variant Takotsubo Cardiomyopathy Associated with Cannabinoid Hyperemesis Syndrome: A Case Report (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998230/
Cannabinoid hyperemesis should be recognised as an effect of chronic cannabis abuse (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129569/
Case of cannabinoid hyperemesis syndrome with long-term follow-up (full–2014) http://www.wjgnet.com/2307-8960/full/v2/i12/930.htm
Cannabinoid Hyperemesis Syndrome: A Case Report and Review of Pathophysiology (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24667219
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS) (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24792504
Cannabinoid Hyperemesis Syndrome: An Emerging Drug-Induced Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24413371
No opiates against cannabis hyperemesis syndrome (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24519114
Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25393073
Cannabinoid hyperemesis syndrome: About 6 cases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25547957
Cyclic Vomiting Presentations Following Marijuana Liberalization in Colorado (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469074/
Cannabinoid Hyperemesis Syndrome: Descriptive Overview of an Under-Recognized Diagnosis (full–2015) http://www.ima.org.il/FilesUpload/IMAJ/0/146/73215.pdf
Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic (full–2015) http://www.ccjm.org/index.php?id=107953&tx_ttnews%5Btt_news%5D=412809&cHash=0c1f8670f2fa499ee88aeff79ee2a47e
Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect (full–2015) http://www.hindawi.com/journals/crigm/2015/405238/
top

13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25733759
Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25896565
Novel case of synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure (abst–2015) http://www.ajemjournal.com/article/S0735-6757%2815%2900743-3/abstract
Cannabinoid Hyperemesis Syndrome? Bring on the Hot Sauce (article–2015)  http://journals.lww.com/em-news/blog/BreakingNews/Pages/post.aspx?PostID=183
Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using A non-classical cannabinoid syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25567676
Cannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874760/ Cannabinoid hyperemesis syndrome as an unusual cause of cyclic vomiting (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919975/
Hypophosphatemia in Users of Cannabis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27692442
Cannabinoid Hyperemesis Syndrome: A Case Report of Cyclic Severe Hyperemesis and Abdominal Pain with Long-Term Cannabis Use (full–2016) https://www.hindawi.com/journals/crigm/2016/2815901/
Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using  Haloperidol in the Outpatient Setting (link to full–2016)  https://www.hindawi.com/journals/crips/2016/3614053/
An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of  Jejunum on the Way to Unravel Her Hyperemesis Enigma (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26757305
Cannabinoid hyperemesis syndrome masquerading as an eating disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26842268
Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27485997
Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757817
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a  Systematic Review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28000146
Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28052951
Synthetic cannabinoids in the kidneys (full–2017) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000100010&lng=en&nrm=iso&tlng=en
Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition,  diagnosis, acute and long-term treatment (full–2017)  http://www.egms.de/static/en/journals/gms/2017-15/000247.shtml
Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic  nervous system? (full–2017) http://www.medical-hypotheses.com/article/S0306-9877(17)30134-2/fulltext
Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series (link to download–2017) https://www.ncbi.nlm.nih.gov/pubmed/29122973
Cannabinoid hyperemesis syndrome: a report of two cases (click “Full Text Links” for download–2017) https://www.ncbi.nlm.nih.gov/pubmed/28186319
Perspectives in the treatment for cannabinoid hyperemesis syndrome (link to PDF-2017)  http://www.adicciones.es/index.php/adicciones/article/view/875
Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28370228
Diagnosis of cannabinoid hyperemesis : update on the cannabis-shower syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28387093
Role of cannabis in digestive disorders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27792038
Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency  department: a case series (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1324166?journalCode=ictx20
Running Out of Options: Rhabdomyolysis Associated with Cannabis Hyperemesis  Syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28664257
Effects of the 2009 Medical Cannabinoid Legalization Policy on Hospital Use for  Cannabinoid Dependency and Persistent Vomiting (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28711691
Capsaicin topical in emergency department treatment of cannabinoid hyperemesis  syndrome (abst–2017) http://www.ajemjournal.com/article/S0735-6757(17)30488-6/fulltext
A case of cannabinoid hyperemesis syndrome with heliobacter pylori and pre-eclampsia
during pregnancy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28723278
Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin
and hot water hydrotherapy in treatment (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1349910?journalCode=ictx20
Cannabinoid hyperemesis syndrome presentation to the emergency department: A two year multicentre retrospective chart review in a major urban area (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28835305
Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28953512
Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use
Disorder: US Trends From 2006 to 2013 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29095419
Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30533-1/fulltext
Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency  Department (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29310960
Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of  Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29320384
The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana
Smokers in an Urban Public Hospital (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29327809
Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin  (abst–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758720/


CARPAL TUNNEL SYNDROME +
Use of palmitoylethanolamide in the entrapment neuropathy of the median in the wrist (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21483401
Comparison of shock wave therapy and nutraceutical composed of Echinacea angustifolia, alpha lipoic acid, conjugated linoleic acid and quercetin (perinerv) in patients with carpal tunnel syndrome (full–2015) http://iji.sagepub.com/content/early/2015/04/30/0394632015584501.long


CATALEPSY
Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5- HT1A receptors activation in mice (full–2013) http://www.sciencedirect.com/science/article/pii/S0278584613001164
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid  Δ9-THC in mice: inhalation versus intraperitoneal injection (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340656/
CB1 cannabinoid receptor-mediated anandamide signalling mechanisms of the inferior
colliculus modulate the haloperidol-induced catalepsy (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27595886
GPR55: A therapeutic target for Parkinson’s disease? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817303842
An endocannabinoid uptake inhibitor from black pepper exerts pronounced antiinflammatory effects in mice (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jafc.7b02979


CATATONIA
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23670023
Could spice drugs induce psychosis with abnormal movements similar to catatonia? (1st page–2014) http://guilfordjournals.com/doi/abs/10.1521/psyc.2014.77.2.206
Catatonia and Cannabis Withdrawal: a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247767
Catatonia secondary to synthetic cannabinoid use in two patients with no previous psychosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26781357


CELIAC DISEASE +
Abnormal anandamide metabolism in celiac disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22209002
The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention (abst–2012) http://www.sciencedirect.com/science/article/pii/S1043661812000540
Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062078


CEREBRAL PALSY
Cannabinoid mouth spray brought help to a severely spastic young man (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25158585
top


CHAGAS DISEASE/AMERICAN TRYPANOSOMIASIS
Trans-sialidase Stimulates Eat Me Response from Epithelial Cells (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/tra.12078/full
Synergistic Effect of Lupenone and Caryophyllene Oxide against Trypanosome cruzi  (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671683/


CHEMICAL COMPOSITION*+
Cannabinoid and Terpenoid Reference Guide (undated)  http://steephilllab.com/resources/cannabinoid-and-terpenoid-reference-guide/
Δ9-Tetrahydrocannabinol content in cannabis samples seized in Novi Sad during 2008 (full–2010) http://www.shd.org.rs/JSCS/Vol75/No7/02_4595_4015.pdf
In silicio expression analysis of PKS genes isolated from Cannabis sativa L (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036156/?tool=pubmed
QUALITY OF HEMP SEED OIL DEPENDING ON ITS OBTAINING (abst–2010) http://www.potravinarstvo.com/journal1/index.php/potravinarstvo/article/view/32
Stable isotope models to predict geographic origin and cultivation conditions of marijuana (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20470741
Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes (abst–2010)
http://www.ncbi.nlm.nih.gov/pubmed/21040939
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1185945
The results of an experimental indoor hydroponic Cannabis growing study, using the ‘Screen of Green’ (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20462712
Variation in Δ9-THC and other Cannabinoids Content in Field Grown Cannabis sativa L During Different Stages of Growth (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1251775
Evaluating the Quality of Protein from Hemp Seed (Cannabis sativa L.) Products
Through the use of the Protein Digestibility-Corrected Amino Acid Score Method (abst-2010) http://pubs.acs.org/doi/abs/10.1021/jf102636b
Analytical Characterization of Hempseed (Seed of Cannabis sativa L.) Oil from Eight
Regions in China (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/22435611
Cannabis as a Unique Functional Food (full–2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
Changes of photosynthesis-related parameters and productivity of Cannabis sativa under different nitrogen supply (full–2011) http://eeb.lu.lv/EEB/201108/EEB_9_Malceva.pdf
top

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Heterogeneity in the composition of marijuana seized in California (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118261/pdf/nihms-271313.pdf
How hemp got high (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333771/
Isolation and Characterization of Edestin from Cheungsam Hempseed (link to PDF–2011) http://koreascience.or.kr/article/ArticleFullRecord.jsp?cn=E1OOBF_2011_v54n2_84
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail (download–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055937/pdf/nihms267227.pdf
Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp
(Cannabis sativa L.) (download–2011) http://www.doiserbia.nb.rs/img/doi/0534-0012/2011/0534-00121103449S.pdf
How Accurate is Potency Testing? (download–2011)  http://www.canorml.org/RingTestOShaughnessys_Aut11.pdf
Isolation and Characterization of Edestin from Cheungsam Hempseed (link to PDF–2011) http://koreascience.or.kr/article/ArticleFullRecord.jsp?cn=E1OOBF_2011_v54n2_84
Characteristics of cannabinoids composition of Cannabis plants grown in Northern Thailand and its forensic application (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21636228
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21798112
Bioactive Prenylogous Cannabinoid from Fiber Hemp (Cannabis sativa) (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21902175
Cadmium Tolerance and Bioaccumulation of 18 Hemp Accessions (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21938417
Cannabinoids: occurrence and medicinal chemistry (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21254969/abstract/Cannabinoids:_occurrence_and_medicinal_chemistry_
Cannabis profiling based on its elemental composition–is it possible? (abst–2011) http://marijuana.researchtoday.net/archive/8/9/4858.htm
Variations in Photosynthesis, Transpiration, Water Use and Cannabinoid Contents in Field Grown Drug Type Varieties of Cannabis sativa L. (abst–2011) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0031-1273536
The Effect of Electrical Lighting Power and Irradiance on Indoor-Grown Cannabis
Potency and Yield (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211717
A real-time PCR assay for the relative quantification of the tetrahydrocannabinolic acid
(THCA) synthase gene in herbal Cannabis samples (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22093702
VARIATIONS IN TERPENE PROFILES OF DIFFERENT STRAINS OF CANNABIS
SATIVA L. (abst–2011) http://www.actahort.org/members/showpdf?booknrarnr=925_15
Analysis of Cannabinoids from Leaves of Ancient Cannabis sativa Found in Yanghai
Xinjiang, China (abst–2011) http://www.trcw.ac.cn/EN/abstract/abstract8457.shtml
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L. under Slow Growth Conditions (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273532
Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides (full–2012) http://www.pnas.org/content/early/2012/07/10/1200330109.long
Isolation and characterization of some phytochemicals from Indian traditional plants (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529893/
The hexanoyl-CoA precursor for cannabinoid biosynthesis is formed by an acylactivating enzyme in Cannabis sativa trichomes (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-313X.2012.04949.x/full
Terpenoid biosynthesis in trichomes—current status and future opportunities (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1467-7652.2012.00737.x/full
top

Cannabis Strains: Do Cannabis Strains Differ? (article–2012) http://www.cannabis-med.org/index.php?tpl=faq&red=faqlist&id=278&lng=en
Cannabis Genome Uncloaked: Commentary on the Scientific Implications (article–2012) http://www.icrs.co/content/Cannabis_Genome_Uncloaked.pdf
Is today’s marijuana more potent simply because it’s fresher? (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/dta.1430/full
Proteomic profiling of hempseed proteins from Cheungsam (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22040604
Cannabis – from cultivar to chemovar (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22362625
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22411724
Chemiluminescence detection of cannabinoids and related compounds with acidic potassium permanganate (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22461321
Structure and Function of Δ1-Tetrahydrocannabinolic Acid (THCA) Synthase, the Enzyme Controlling the Psychoactivity of Cannabis sativa (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22766313
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23280038
Studies on the Optimization of Agrotechniques to Maximize the Productivity of Two Cannabis Chemotypes Cultivated to Produce Medicinal Grade Plant Material (abst–2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1307524
First systematic evaluation of the potency of Cannabis sativa plants grown in Albania (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22608266
Cannabis, a complex plant: different compounds and different effects on individuals (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
Early Phenylpropanoid Biosynthetic Steps in Cannabis sativa: Link between Genes and Metabolites (full–2013) http://www.mdpi.com/1422-0067/14/7/13626/htm
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants (link to PDF-2013) http://www.mdpi.com/1420-3049/18/10/12663
Chemical Composition and Characterization of Hemp (Cannabis sativa) Seed oil and
essential fatty acids by HPLC Method (full–2013)  http://www.scholarsresearchlibrary.com/articles/chemical-composition-and-characterization-of-hemp-cannabis-sativa-seed-oil-and-essential-fatty-acids-by-hplc-method.pdf
In planta imaging of Δ9-tetrahydrocannabinolic acid in Cannabis sativa L. with hyperspectral coherent anti-Stokes Raman scattering microscopy (full–2013) http://os.tnw.utwente.nl/publications/pdf/237.pdf
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0070052
Ethephon application stimulates cannabinoids and plastidic terpenoids production in Cannabis sativa at flowering stage (abst–2013) https://www.mysciencework.com/publication/show/ethephon-application-stimulats-cannabinoids-andplastidic-terpenoids-production-incannabis-sativaat-flowering-stage
Biotransformation of cannabinoids by a cell suspension culture of Cannabis sativa L (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24248499
Chemical profiling of different hashish seizures by gas chromatography-mass spectrometry and statistical methodology: a case report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24008198
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23588562
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24115748
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1352335
top

Study of leaf metabolome modifications induced by UV-C radiations in representative Vitis, Cissus and Cannabis species by LC-MS based metabolomics and antioxidant assays (full–2014) http://www.mdpi.com/1420-3049/19/9/14004/htm
Affinity comparison of different THCA synthase to CBGA using modeling computational approaches (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916817/
Influence of mevinolin on chloroplast terpenoids in Cannabis sativa (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988329/
Targeted mutation of Δ12 and Δ15 desaturase genes in hemp produce major alterations in seed fatty acid composition including a high oleic hemp oil (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/pbi.12167/epdf
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Amber is Bad ? (article–2014) http://growhappyplants.com/look.html
Variability of cannabis potency in the Venice area (Italy): A survey over the period 2010-2012 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23868754
Hemp (Cannabis sativa L.) seed oil: Analytical and phytochemical characterization of unsaponifiable fraction (abst–2014) http://pubs.acs.org/doi/abs/10.1021/jf404278q
Metals and organic compounds in the biosynthesis of cannabinoids: a chemometric approach to the analysis of Cannabis sativa samples (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/24483128
A PCR marker Linked to a THCA synthase Polymorphism is a Reliable Tool to Discriminate Potentially THC-Rich Plants of Cannabis sativa L. (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24579739
Molecular characterization of edestin gene family in Cannabis sativa L. (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25280223
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/24934168
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Structural and functional properties of hemp seed protein products (abst–2014)  https://www.ncbi.nlm.nih.gov/pubmed/25048774
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Minor oxygenated cannabinoids from high potency Cannabis sativa L (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26093324
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol (full–2015) http://file.scirp.org/Html/5-2500582_53912.htm
Cannabinoids Production by Hairy Root Cultures of Cannabis sativa L (full–2015) http://file.scirp.org/Html/21-2601738_58491.htm
Method for the Analysis of Cannabinoids and Terpenes in Cannabis (link to PDF–2015) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=7
Sequence heterogeneity of cannabidiolic- and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25865737
Seized cannabis seeds cultivated in greenhouse: A chemical study by gas chromatography–mass spectrometry and chemometric analysis (full–2015)
http://www.scienceandjusticejournal.com/article/S1355-0306%2815%2900111-2/fulltext
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25492688
Evaluation of elemental profiling methods, including laser-induced breakdown spectroscopy (LIBS), for the differentiation of Cannabis plant material grown in different nutrient solutions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25898182
top

(1)H NMR and HPLC/DAD for Cannabis sativa L chemotype distinction, extract profiling and specification (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria – Impact of different storage temperatures on stability (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247127
Cannabis and Endocannabinoid Signaling in Epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408165
Expression, purification and crystallization of a plant polyketide cyclase from Cannabis sativa (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26625288
Determination of 11 Cannabinoids in Biomass and Extracts of Different Varieties of Cannabis Using High-Performance Liquid Chromatography (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26651563
Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana) (abst–2015) http://link.springer.com/article/10.1007/s10722-015-0254-2
Biotransformation of Tetrahydrocannabinol (abst–2015) http://link.springer.com/article/10.1007/s11101-015-9438-9
Evolution and Classification of Cannabis sativa (Marijuana, Hemp) in Relation to Human Utilization (abst–2015) http://link.springer.com/article/10.1007/s12229-015-9157-3
Expansion of female sex organs in response to prolonged virginity in Cannabis sativa (marijuana) (abst–2015) http://www.agr.gc.ca/eng/abstract/?id=35387000000564
Effect-directed analysis of cold-pressed hemp, flax and canola seed oils by planar
chromatography linked with (bio)assays and mass spectrometry (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0308814615005890
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
Harvesting the biosynthetic machineries that cultivate a variety of indispensable plant natural products (full–2016) http://www.sciencedirect.com/science/article/pii/S1367593116000041
Cannabis sativa: The Plant of the Thousand and One Molecules (full–2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00019/full
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid (full–2016) http://online.liebertpub.com/doi/10.1089/can.2015.0004
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes (full-2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00688/full
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/
A Belated Green Revolution for Cannabis: Virtual Genetic Resources to Fast-Track Cultivar Development (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965456/
Analysis of a commerical marijuana e-cigarette formulation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867395/
Monitoring Metabolite Profiles of Cannabis sativa L. Trichomes during Flowering Period
Using 1H NMR-Based Metabolomics and Real-Time PCR (full–2016) https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0042-108058
The Name of Cannabis: A Short Guide for Nonbotanists (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531363/
Transcriptome differences between fiber-type and seed-type Cannabis sativa variety
exposed to salinity (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120038/
Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal
Markets (link to PDF–2016) http://biorxiv.org/content/early/2016/10/26/083444
Structural basis for olivetolic acid formation by a polyketide cyclase from Cannabis sativa (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26783002
Changes in cannabis potency over the last two decades (1995-2014) – Analysis of current data in the United States (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006322316000457
Chapter 2 – Biosynthesis and Pharmacology of Phytocannabinoids and Related Chemical Constituents (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000023
Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jnatprod.5b00949
The influences of cultivation setting on inflorescence lipid distributions, concentrations, and carbon isotope ratios of Cannabis sp. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27045381
In Vitro Propagation of Cannabis sativa L. and Evaluation of Regenerated Plants for Genetic Fidelity and Cannabinoids Content for Quality Assurance (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27108324
Seed composition of ten industrial hemp cultivars approved for production in Canada (abst–2016) http://www.sciencedirect.com/science/article/pii/S088915751400194X
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303638
Near infrared spectroscopy combined with chemometrics for growth stage classification of cannabis cultivated in a greenhouse from seized seeds (abst–2016) http://www.sciencedirect.com/science/article/pii/S1386142516305583
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27763968
Bioactive spirans and other constituents from the leaves of Cannabis sativa f. sativa (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27848262
A study of cannabis potency in France over a 25 years period (1992-2016) (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28122324
Polyphenolic Compounds and Antioxidant Activity of Cold-Pressed Seed Oil from Finola
Cultivar of Cannabis sativa L. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27076277
Quality Control of Traditional Cannabis Tinctures: Pattern, Markers, and Stability (full–2017) http://www.mdpi.com/2218-0532/84/3/567/htm
Determination of delta-9-tetrahydrocannabinol content of cannabis seizures in Egypt  (full–2017) http://www.sciencedirect.com/science/article/pii/S1995764516304266
In silico discovery of terpenoid metabolism in Cannabis sativa (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482328/
Training and Practices of Cannabis Dispensary Staff (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531366/
Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans:
Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102–112;
DOI: 10.1089/can.2015.0004 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531368/
Conversion of Cannabidiol Following Oral Administration: Authors’ Response to
Grotenhermen et al. DOI: 10.1089/can.2016.0036 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569618/
A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur
in Humans (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510776/
Identification of Terpenoid Chemotypes Among High (−)-trans-Δ9-
Tetrahydrocannabinol-Producing Cannabis sativa L. Cultivars (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436332/
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol
and Cannabidiol on Human Cognition (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435777/
Terpene synthases from Cannabis sativa (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0173911
Broad-Scale Genetic Diversity of Cannabis for Forensic Applications (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249207/
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation
and Pain (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/
Evaluation of long-term stability of cannabinoids in standardized preparations of
cannabis flowering tops and cannabis oil by ultra-high-performance liquid
chromatography tandem mass spectrometry (full–2017)  https://www.degruyter.com/view/j/cclm.ahead-of-print/cclm-2017-0758/cclm-2017-0758.xml
Cannabidiol Does Not Convert to Δ9-Tetrahydrocannabinol in an In Vivo Animal Model  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744690/
Psychoactive constituents of cannabis and their clinical implications: a systematic review (link to download–2017)  http://adicciones.es/index.php/adicciones/article/view/858/863
Phytochemistry of Cannabis sativa L. (abst–2017)  http://link.springer.com/chapter/10.1007%2F978-3-319-45541-9_1
The Bibenzyl Canniprene Inhibits the Production of Pro-Inflammatory Eicosanoids and
Selectively Accumulates in Some Cannabis sativa Strains (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jnatprod.6b01126
Raman spectroscopy for the characterization of different fractions of hemp essential oil
extracted at 130°C using steam distillation method (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1386142517302585?via%3Dihub
Recommendation to reconsider examining cannabis subtypes together due to opposing
effects on brain, cognition and behavior (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28579491
Differentiation of Cannabis subspecies by THCA synthase gene analysis using RFLP  (abst–2017) http://www.jflmjournal.org/article/S1752-928X(17)30104-X/fulltext
Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads (abst–2017) http://www.sciencedirect.com/science/article/pii/S1054358917300273?via%3Dihub
A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the
Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal
Extracts (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28915313
Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to  Supercritical CO2 Concentrate (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28926863
Pharmacological Foundations of Cannabis Chemovars (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29161743
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics
studies of cannabidiolic acid (CBDA) (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0731708517322367?via%3Dihub
A natural product from Cannabis sativa subsp. sativa inhibits homeodomain-interacting
protein kinase 2 (HIPK2), attenuating MPP+-induced apoptosis in human neuroblastoma
SH-SY5Y cells (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0045206816303972
Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of
Cannabis sativa Using GC-FID (abst–2017) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-124088
The application of plant in vitro cultures in cannabinoid production (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29249063
Exploration of Potentially Bioactive Peptides Generated from the Enzymatic Hydrolysis
of Hempseed Proteins (abst–2017) http://pubs.acs.org/doi/10.1021/acs.jafc.7b03590
The crop-residue of fiber hemp cv. Futura 75: from a waste product to a source of
botanical insecticides (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29105041
Cannabinomimetric Lipids: From Natural Extract to Artificial Synthesis (full–2018)  https://link.springer.com/article/10.1007%2Fs13659-017-0151-9


CHEMICAL INTOLERANCE/CHEMICAL SENSITIVITY
Levels of oxylipins, endocannabinoids and related lipids in plasma before and after low level exposure to acrolein in healthy individuals and individuals with chemical  intolerance (abst–2017) http://www.plefa.com/article/S0952-3278(16)30153-3/fulltext


CHEMOTHERAPY*+
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869084/?tool=pubmed
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997305/pdf/bcp0070-0656.pdf
Mechanisms of Broad-Spectemetic Efficacy of Cannabinoids against Chemotherapy Induced Acute and Delayed Vomiting (link to PDF–2010) http://www.mdpi.com/1424-8247/3/9/2930
Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249239/
top

Regulation of nausea and vomiting by cannabinoids (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.01176.x/pdf
A combined preclinical therapy of cannabinoids and temozolomide against glioma (full–2011) http://mct.aacrjournals.org/content/10/1/90.full
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid  antitumoral action (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131933/
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells
through a ROS-mediated mechanism (full–2011)  http://www.nature.com/cddis/journal/v2/n4/pdf/cddis201136a.pdf
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Biotechnology of Cannabis sativa L. (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273535
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366638/
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy (full–2012) http://www.molecularpain.com/content/8/1/71
β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312970/
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525790/
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to
cytotoxic chemotherapeutic agents (full–2012)  http://carcin.oxfordjournals.org/content/34/1/48.long
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA
MB 231 cells (full–2012) http://www.ejcancer.com/article/S0959-8049%2812%2900216-X/fulltext
Cannabinoids: A new hope for breast cancer therapy? (full-2012)  http://www.academia.edu/23263803/Cannabinoids_A_new_hope_for_breast_cancer_therapy
Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent
Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer (full–2012)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924623/
Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22491047
Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced
peripheral neuropathy in rats. Possible involvement of spinal glial cells (abst–2012)
http://www.ncbi.nlm.nih.gov/pubmed/22374260
Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682714/
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2 (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/ijc.28591/full
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain (full–2013) http://www.jpsmjournal.com/article/S0885-3924%2813%2900238-8/fulltext
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care (full–2013) http://cannabisclinicians.org/wp-content/uploads/2013/09/Med-Nec-for-Cannabis-in-Cancer-Israel.pdf
Characterisation of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454533
Additive antiemetic efficacy of 9-THC with vanilloid TRPV1 receptor agonists in the least shrew (Cryptotis parva) (abst-2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1093.20?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23721741
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24157976
Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24012649
top

Spinal gene expression profiling and pathways analysis of a CB2 agonist (MDA7)-targeted prevention of paclitaxel-induced neuropathy (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24361916
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969077/
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases (full–2014)
http://www.jpp.krakow.pl/journal/archive/04_14/pdf/183_04_14_article.pdf
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
Medical marijuana for cancer (full–2014) http://onlinelibrary.wiley.com/doi/10.3322/caac.21260/full
Medical marijuana: more questions than answers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243838/
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268146/
Activation of G-protein-coupled receptor 40 attenuates the cisplatin-induced apoptosis of human renal proximal tubule epithelial cells (full–2014)
http://www.spandidos-publications.com/ijmm/34/4/1117
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24853387
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25505113
Report on Medical Cannabis Research History- What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25145507
HU-331 Is a Catalytic Inhibitor of Topoisomerase Iiα (abst–2014) http://pubs.acs.org/doi/abs/10.1021/tx500245m
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/ptr.5265/full
Cannabidiol protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis (full–2015) http://static.smallworldlabs.com/molmedcommunity/content/pdfstore/14_261_Hao.pdf
Coadministration of indomethacin and minocycline attenuates established paclitaxel induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors (full–2015) http://www.nature.com/srep/2015/150618/srep10541/pdf/srep10541.pdf
Cannabis and Cannabinoids–for health professionals (PDQ®) (full–2015) http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
top

Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (abst–2015) http://www.sciencedirect.com/science/article/pii/S0885392414003121
CB1 Knockout Mice Unveil Sustained CB2-Mediated Anti-Allodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25904556
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009464.pub2/full
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2. (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580018/
Controlled release tablet formulation containing natural δ9 tetrahydrocannabinol (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098422/
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science (interview–2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lestergrinspoon/
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015)  http://jama.jamanetwork.com/article.aspx?articleid=2338230
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058312
Peroxisome Proliferator-Activated Receptor-α Inhibition Protects Against Doxorubicin Induced Cardiotoxicity in Mice (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26082188
Endocannabinoid Mechanisms Influencing Nausea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638766
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=9663&path%5B%5D=30267
Cannabis and cancer: toward a new understanding (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791146/
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869612/
Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161954
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path%5B%5D=12721&path%5B%5D=40316
Anticancer mechanisms of cannabinoids (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/
Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex
interferes with anticipatory nausea in a rat model (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793281/
Why I chose to use cannabis (article–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791147/
Using Medical Cannabis in an Oncology Practice (article–2016) http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncologypractice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27214593 Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Effect of combined oral doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27438607
May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686064
Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27821713
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27993113
An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of
Jejunum on the Way to Unravel Her Hyperemesis Enigma (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26757305
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Overview of Chemotherapy-Induced Nausea and Vomiting and Evidence-Based
Therapies (full–2017) http://www.ajmc.com/journals/supplement/2017/managed-care-considerations-in-chemotherapy-induced-nausea-andvomiting/overview-of-chemotherapy-induced-nausea-and-vomiting-and-evidence-based-therapies-article/
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the
intestinal lymphatic system and prominent immunomodulation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674070/
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663723/
Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies (full–2017)  http://apm.amegroups.com/article/view/16320/16484
The slowly signaling G protein-biased CB2 cannabinoid receptor agonist LY2828360
suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance
and dependence (link to download–2017)  http://molpharm.aspetjournals.org/content/early/2017/11/30/mol.117.109355.long
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
Systematic review of safeness and therapeutic efficacy of cannabis in patients with
multiple sclerosis, neuropathic pain, and in oncological patients treated with
chemotherapy (abst in English–2017) https://www.ncbi.nlm.nih.gov/pubmed/29119763
(full in Italian) http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabis-
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28235999
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27778331
Cannabinoids as gastrointestinal anti-inflammatory drugs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28239924
Single and combined effects of delta9 -tetrahydrocannabinol and cannabidiol in a mouse
model of chemotherapy-induced neuropathic pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28548225
Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can
be improved by altering the sequence of their administration (abst–2017)  https://www.spandidos-publications.com/10.3892/ijo.2017.4022
Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in
mice (abst–2017) http://www.sciencedirect.com/science/article/pii/S0028390817303465?via%3Dihub
Cannabinoids as Anticancer Drugs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826542
Medical Cannabinoids in Children and Adolescents: A Systematic Review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061872
Cannabinoids for nausea and vomiting related to chemotherapy: Overview of systematic
reviews (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29168289
Cannabidiol: an alternative therapeutic agent for oral mucositis? (abst–2017) 
https://www.ncbi.nlm.nih.gov/pubmed/28191662
Are cannabinoids effective for the management of chemotherapy induced nausea and
vomiting? (abst in English, link to abst in Spanish–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29286355
HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase IIα and β  (abst–2017) https://pubs.acs.org/doi/10.1021/acs.chemrestox.7b00302
The therapeutic effects of Cannabis and cannabinoids: An update from the National
Academies of Sciences, Engineering and Medicine report (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29325791
Medical Cannabis: The Oncology Nurse’s Role in Patient Education About the Effects of
Marijuana on Cancer Palliation (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29350699


CHEST PAIN-NON CARDIAC
A 4-Week Pilot Study With the Cannabinoid Receptor Agonist Dronabinol and Its Effect
on Metabolic Parameters in a Randomized Trial (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26283236
Dronabinol increases pain threshold in patients with functional chest pain: a pilot doubleblind placebo-controlled trial (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26822791


CHILD ABUSE/NEGLECT
PTSD contributes to teen and young adult cannabis use disorders (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784238/?tool=pubmed
Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse
on Anhedonia and Depression (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706194/
Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT
genotypes (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23445265
Childhood and current ADHD symptom dimensions are associated with more severe
cannabis outcomes in college students (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904106/
The Association of Low Parental Monitoring With Early Substance Use in European
American and African American Adolescent Girls (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712655/
Inhibition of anandamide hydrolysis dampens the neuroendocrine response to stress in
neonatal rats subjected to suboptimal rearing conditions (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26552023
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis  (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415302943
Substantiated childhood maltreatment and young adulthood cannabis use disorders: A
pre-birth cohort study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31722-X/fulltext
Impulsivity as a mechanism linking child abuse and neglect with substance use in
adolescence and adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28606210
Associations of Bullying and Cyberbullying With Substance Use and Sexual Risk Taking
in Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605163
Phenotypic and familial associations between childhood maltreatment and cannabis
initiation and problems in young adult European-American and African-American
women (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30373-3/fulltext
Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders:
variation by race/ethnicity? (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29310741


CHILDREN
Endocannabinoid (EC) Receptor, CB1, and EC Enzymes’ Expression in Primary Adipocyte Cultures of Lean and Obese Pre-pubertal Children in Relation to Adiponectin and Insulin (abst–2010) http://www.degruyter.com/abstract/j/jpem.2010.23.issue-10/jpem.2010.162/jpem.2010.162.xml?rskey=38kdx0&result=22&q=cannabinoid
Dronabinol for the treatment of unspecific pain, restlessness and spasticity in neuropaediatrics (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1265622
A short-term, quasi-experimental evaluation of D.A.R.E.’s revised elementary school curriculum (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/21038762
Evaluating the Quality of Protein from Hemp Seed (Cannabis sativa L.) Products
Through the use of the Protein Digestibility-Corrected Amino Acid Score Method (abst-2010) http://pubs.acs.org/doi/abs/10.1021/jf102636b
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
Examining the Health and Drug Exposures among Canadian Children Residing in Drug Producing Homes (abst–2011) http://www.jpeds.com/article/S0022-3476%2811%2900522-1/abstract
top

Greasing the wheels of managing overweight and obesity with omega-3 fatty acids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210336/
Immune thrombocytopenia in children and adults: what’s the same, what’s different?  (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232253/
Early exposure to Environmental enrichment alters the expression of genes of the  endocannabinoid system (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21419109/abstract/Early_exposure_to_Environmental_enrichment_alters_the_expression_of_genes_of_the_endocannabinoid_system_
Accidental cannabis poisoning in children: report of four cases in a tertiary care center from southern Spain (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21283933/abstract/%5BAccidental_cannabis_poisoning_in_children:_report_of_four_cases_in_a_tertiary_care_center_from_southern_Spain%5D_
Pediatric cannabinoid hyperemesis: two cases (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21131803
Cannabinoids in children (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=295
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042259
Intelligence quotient in childhood and the risk of illegal drug use in middle-age: the 1958 National Child Development Survey (full-2012) http://www.annalsofepidemiology.org/article/S1047-2797%2812%2900170-6/fulltext
Parental Monitoring at Age 11 and Subsequent Onset of Cannabis Use Up to Age 17:
Results From a Prospective Study (full–2012)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281976/
Childhood Obesity and the Role of Dopamine D2 Receptor and Cannabinoid Receptor-1 Gene Polymorphisms (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23057570
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment resistant epilepsy (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/
The role of child protection in cannabis grow-operations (full–2013) http://www.canorml.org/child.welfare.pdf
Childhood immune thrombocytopenia-who will spontaneously recover? (full–2013)  http://www.seminhematol.org/article/S0037-1963%2813%2900032-2/fulltext
Anticipated Medical Effects on Children From Legalization of Marijuana in Colorado and Washington State (1st page–2013) http://archpedi.jamanetwork.com/article.aspx?articleid=1691419&resultClick=3
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23406660
Methadone and illegal drugs in hair from children with parents in maintenance treatment or suspected for drug abuse in a German community (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24263638
The case for medical marijuana in epilepsy (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12610/full
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Pediatric exposure to drugs of abuse by hair testing: monitoring 15 years of evolution in Spain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143861/
The consequences of pain in early life: injury-induced plasticity in developing pain pathways (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264936/
Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904106/
Cannabinoid findings in children hair – what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9-tetrahydrocannabinolic acid A concentrations (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/dta.1692/full
Modulation of early stress-induced neurobiological changes: a review of behavioural and
pharmacological interventions in animal models (full–2014)  http://www.nature.com/tp/journal/v4/n5/full/tp201431a.html
Physicians, Medical Marijuana, and the Law (full–2014) http://journalofethics.ama-assn.org/2014/09/hlaw1-1409.html
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases (link to upload-2014) http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement
top

EFFICACY AND SAFETY OF EPIDIOLEX (CANNABIDIOL) IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY: INITIAL DATA FROM AN EXPANDED ACCESS PROGRAM (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868751#sthash.pbnOqzNG.dpuf
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868391#sthash.uxbwgudh.dpuf
Intoxication from accidental ingestion of hashish: Analysis of eight cases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25466782
Medical marijuana and children (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25647865
RESOLUTION OF SEIZURES AND NORMALIZATION OF EEG AFTER INITIATION OF CBD IN A PATIENT WITH DOOSE SYNDROME (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868186#sthash.4suBa1in.dpuf
The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140142
Medical marijuana’s public health lessons–implications for retail marijuana in Colorado (full–2015) http://www.nejm.org/doi/full/10.1056/NEJMp1500043
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318349/
Association between paracetamol use in infancy or childhood with body mass index (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/oby.21045/full
Use of paracetamol during pregnancy and child neurological development (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/dmcn.12745/full
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700831/
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/epi.13060/full
Urinary early kidney injury molecules in children with beta-thalassemia major (full–2015) http://www.tandfonline.com/doi/full/10.3109/0886022X.2015.1007871
Parental Separation and Early Substance Involvement: Results from Children of
Alcoholic and Cannabis Dependent Twins (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908916/
Perinatal asphyxia results in altered expression of the hippocampal  acylethanolamide / endocannabinoid signaling system associated to memory impairments in post weaned rats (full–2015)  http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0149763415001244
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial (abst–2015) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2815%2900379-8/abstract
The maternal deprivation animal model revisited (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25616179
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25845492
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25974389
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
top

Cannabidiol as potential treatment in refractory pediatric epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26567560
Hair analysis for Δ(9) -tetrahydrocannabinolic acid A (THCA-A) and Δ(9) –
tetrahydrocannabinol (THC) after handling cannabis plant material (abst–2015)
https://www.researchgate.net/publication/278895867_Hair_analysis_for_D9-tetrahydrocannabinolic_acid_A_THCA-A_and_D9-
tetrahydrocannabinol_THC_after_handling_cannabis_plant_material
Options for pharmacoresistant epilepsy in children: when medications don’t work (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25658218
Inhibition of anandamide hydrolysis dampens the neuroendocrine response to stress in
neonatal rats subjected to suboptimal rearing conditions (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26552023
The Pharmacological Basis of Cannabis Therapy for Epilepsy (full–2016) http://jpet.aspetjournals.org/content/early/2016/01/19/jpet.115.230151.long
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/prp2.220/full
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791143/
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience (abst–2016) http://www.sciencedirect.com/science/article/pii/S1059131116000054
Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/ajmg.b.32467/full
Is the medical use of cannabis a therapeutic option for children? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758425/
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044872/
Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043219/
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United
States, 2002 to 2013 (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957692/
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation (link to PDF-2016) http://press.endocrine.org/doi/10.1210/jc.2015-4381?url_ver=Z39.88-2003&rfr_id=ori%3Arid %3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Deficient adolescent social behavior following early-life inflammation is ameliorated by
augmentation of anandamide signaling (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461973/
Detecting biomarkers of secondhand marijuana smoke in young children (link to PDF–2016) http://www.nature.com/pr/journal/vaop/naam/abs/pr2016261a.html
Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (letter–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3333-6
Medicinal Use of Marijuana: What School Nurses Need to Know (abst–2016)  http://nas.sagepub.com/content/31/3/170.long
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma (abst–2016) http://www.europeanneuropsychopharmacology.com/article/S0924-977X(16)00077-8/abstract
Childhood Maltreatment in the Migraine Patient (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27194425
Cannabinoid Poisoning by Hemp Seed Oil in a Child (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27299295
Marijuana Misadventures in Children: Exploration of a Dose-Response Relationship and Summary of Clinical Effects and Outcomes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27050740
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia (abst–2016) http://www.schres-journal.com/article/S0920-9964(16)30060-3/abstract
Childhood weight status and timing of first substance use in an ethnically diverse sample (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30111-9/abstract
Disturbances of sleep and circadian rhythms: novel risk factors for obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27584008
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (abst–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3243-7
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27659736
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27875353
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27993113
Experience with Gambling in Late Childhood and Early Adolescence: Implications for
Substance Experimentation Behavior (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26836642
Using Medical Marijuana to Stop Childhood Seizures (news & abstract–2016) http://neurosciencenews.com/thc-cbd-childhood-seizures-3618/
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults (full–2017) http://www.sciencedirect.com/science/article/pii/S221315821630170X
Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human
osteosarcoma (full–2017) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=17089&path%5B%5D=54691
Fine particles in homes of predominantly low-income families with children and
smokers: Key physical and behavioral determinants to inform indoor-air-quality
interventions (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0177718
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent
Epilepsy? (full–2017)
http://www.j-epilepsy.org/journal/view.php?year=2017&vol=7&page=16
An Australian nationwide survey on medicinal cannabis use for epilepsy: History of
antiepileptic drug treatment predicts medicinal cannabis use (full–2017)  http://www.epilepsybehavior.com/article/S1525-5050(17)30073-2/fulltext
What effects—if any—does marijuana use during pregnancy have on the fetus or child?  (full–2017) http://www.mdedge.com/jfponline/article/141775/pediatrics/what-effects-if-any-does-marijuana-use-during-pregnancy-have
The oxylipin and endocannabidome responses in acute phase Plasmodium falciparum
malaria in children (full–2017)  https://malariajournal.biomedcentral.com/articles/10.1186/s12936-017-2001-y
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis)
in Mexican Children with Refractory Epilepsy (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28392943
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767492/
The Unintended Consequences of Marijuana Legalization (full–2017)  http://www.jpeds.com/article/S0022-3476(17)31081-8/fulltext
The Role of Cannabinoids in the Treatment of Cancer in Pediatric Patients (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4044
Cannabinoids in treatment-resistant epilepsy: A review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28188044
Caring for Young Children Exposed to Marijuana (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28141605
Social correlates of health status, quality of life, and mood states in patients treated with
cannabidiol for epilepsy (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30731-4/fulltext
A 10-year review of cannabis exposure in children under 3-years of age: do we need a
more global approach? (abst–2017) https://link.springer.com/article/10.1007%2Fs00431-017-2872-5
Substantiated childhood maltreatment and young adulthood cannabis use disorders: A
pre-birth cohort study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31722-X/fulltext
Impulsivity as a mechanism linking child abuse and neglect with substance use in
adolescence and adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28606210
Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in
developing rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28691158
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28538134
Unintentional Cannabis Ingestion in Children: A Systematic Review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28888560
Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human
osteosarcoma (abst–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589594/
Medical Cannabinoids in Children and Adolescents: A Systematic Review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29061872
Role of Cannabinoid CB2 Receptor Gene (CNR2) Polymorphism in Children with
Immune Thrombocytopenic Purpura in Beni-Suef Governorate in Egypt (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29120578
Cannabis Intoxication Case Series: The Dangers of Edibles Containing  Tetrahydrocannabinol (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29103798
Efficacy and safety of cannabis for treating children with refractory epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Endocannabinoid engagement of CB2 regulates RSV-induced immunity (link to PDF–2018) http://www.tandfonline.com/doi/abs/10.1080/21505594.2017.1421830
Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders:
variation by race/ethnicity? (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29310741
Marijuana-Perinatal and Legal Issues With Use During Pregnancy (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29373417


CHOLERA*+
In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25516242


CHOLESTEROL*+
A common CNR1 (cannabinoid receptor 1) haplotype attenuates the decrease in HDL cholesterol that typically accompanies weight gain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013130/?toolubmed
A randomised, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GW42003 : GW42004 plus GW42003 and GW42004 alone in the treatment of dyslipidaemia in subjects with Type 2 diabetes (research summary–2010)  http://www.hra.nhs.uk/news/research-summaries/gwmd1092-gw42003gw42004-together-plus-alone-intype-ii-diabetes/#sthash.FT2P6YcB.dpuf
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20851297
Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2
cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20380798
Dietary hempseed meal intake increases body growth and shortens the larval stage via the upregulation of cell growth and sterol levels in Drosophila melanogaster (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20652493
Effects of chronic nicotine on food intake and anxiety-like behaviour in CB(1) knockout
mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20189358
The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933972/
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2010.07041.x/full
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically
relevant tissues from high-fat-fed mice (full–2011)  http://www.nutritionandmetabolism.com/content/8/1/51
The Non-Psychoactive Plant Cannabinoid, Cannabidiol Affects Cholesterol Metabolism-Related Genes in Microglial Cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21533611
The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21893466
top
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with coronary
artery disease in the Chinese Han population (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22029183
Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts  (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21575494
Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484111/
Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice (full–2012) http://www.dmsjournal.com/content/4/1/35
Interleukin-1β causes anxiety by interacting with the endocannabinoid system (full–2012) http://www.jneurosci.org/content/32/40/13896.long
CNR1 genotype influences HDL-cholesterol response to change in dietary fat intake (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342253/
Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE) (full–2012) http://fampra.oxfordjournals.org/content/29/5/521.full
EFFECTS OF GRADED LEVELS OF HEMP SEED (CANNABIS SATIVA L.) ON PERFORMANCE, ORGAN WEIGHT AND SERUM CHOLESTEROL LEVELS ON BROILERS (abst–2012) http://en.journals.sid.ir/ViewPaper.aspx?ID=276824
Role of Lipid Rafts/Caveolae in the Anticancer Effect of Endocannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22625418
Treatment with CB 2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice (full–2013) http://www.hindawi.com/journals/cdi/2013/263846/
A common functional promoter variant links CNR1 gene expression to HDL cholesterol level (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873874/
Pathophysiology of Human Visceral Obesity: An Update (full–2013)  http://physrev.physiology.org/content/93/1/359.long
US Patent Application 20130245110 – USE FOR CANNABINOIDS (CBD/ THCV for cholesterol control) (full–2013) http://www.freepatentsonline.com/y2013/0245110.html
GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors (link to PDF–2013) http://www.eurekaselect.com/105678/article
Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24445122
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373
Role of Genetic Variation in the Cannabinoid Receptor Gene (CNR1) (G1359A
Polymorphism) on Weight Loss and Cardiovascular Risk Factors After Liraglutide
Treatment in Obese Patients With Diabetes Mellitus Type 2 (abst–2013)
http://www.ncbi.nlm.nih.gov/pubmed/24322329
Biochemical and immunohistochemical changes in delta-9-tetrahydrocannabinol-treated
type 2 diabetic rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23845579
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the
endocannabinoid system in animal and human adipocytes (full–2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995979/
Association of polymorphisms in the endocannabinoid system genes with myocardial
infarction and plasma cholesterol levels (full–2014)  http://biomed.papers.upol.cz/getrevsrc.php?identification=public&mag=bio&raid=825&type=fin&ver=3
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid
Receptors (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059893/
Sterol Carrier Protein-2: Binding Protein for Endocannabinoids (full–2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450258/
Detailed characterization of the endocannabinoid system in human macrophages and
foam cells, and anti-inflammatory role of type-2 cannabinoid receptor (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/24529123
Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH (abst–2014) http://www.biochemj.org/content/457/3/463
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation (full–2015) http://cardiovascres.oxfordjournals.org/content/early/2015/06/30/cvr.cvv179.long
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation (full–2015)  http://cardiovascres.oxfordjournals.org/content/early/2015/06/30/cvr.cvv179.long
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments (full–2015)
http://www.nature.com/articles/srep15453
METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523241/
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665616/ Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic
cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression (full–2015) http://ajpendo.physiology.org/content/308/7/E583.long
Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic
acid-derived oxylipins and ceramides in mice (full–2015)  http://www.sciencedirect.com/science/article/pii/S0955286315000212
Transgenic ω-3 PUFA enrichment alters morphology and gene expression profile in
adipose tissue of obese mice: Potential role for protectins (full–2015)
http://www.metabolismjournal.com/article/S0026-0495(15)00036-0/fulltext
Participation of the endocannabinoid system (ECS) in the weight-gain and sensitization
to LPS exposure in a maternal obesity model (article–2015)
http://www.placentajournal.org/article/S0143-4004%2815%2900526-3/fulltext
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate  (download–2015) http://www.fasebj.org/content/29/4/1446.full.pdf+html
Polymorphism G1359A of the cannabinoid receptor gene (CNR1): allelic frequencies and
influence on cardiovascular risk factors in a multicentre study of Castilla-Leon (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/25682784
Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macronutrient intakes in obese females (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jhn.12298/full
Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with
macronutrient intakes in obese females (abst–2015)  http://onlinelibrary.wiley.com/doi/10.1111/jhn.12298/full
Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about
New Targets for Reduction of the Atherosclerotic Plaque (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26592248
Abstract 577: Medical Marijuana Use: Effect on Lipid Metabolism and Atherosclerosis  (abst–2015) http://atvb.ahajournals.org/content/35/Suppl_1/A577
top
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data (abst–2016) http://www.sciencedirect.com/science/article/pii/S0002934315010244
Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993868/
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid ReceptorRelated Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00241/full
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens (full–2016) http://www.tandfonline.com/doi/full/10.4081/ijas.2015.3473
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27117865
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo Controlled, Parallel Group Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27573936
Cyclooxygenase-2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006291X16300833
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27465665
Monoglyceride lipase deficiency affects hepatic cholesterol metabolism and lipid dependent gut transit in ApoE-/- mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464855/
Metabolic Syndrome Induced Bladder Cannabinoid Receptor Changes in the Fructose Fed
Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28386998
Inhibitory effect of trans-caryophyllene (TC) on leukocyte-endothelial attachment (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28624443


CHRONIC CEREBRAL HYPOPERFUSION
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816304375


CHRONIC FATIGUE SYNDROME
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (full–2014) http://tinyurl.com/hss39v9


CHRONIC MOUNTAIN SICKNESS
Association Between Plasma N-Acylethanolamides and High Hemoglobin Concentration
in Southern Peruvian Highlanders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28665150


CHRONIC TRAUMATIC ENCEPHALOPATHY/CTE
Endocannabinoids in Synaptic Plasticity and Neuroprotection (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143501/
Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like
neuropathology in a mouse model of repetitive mild closed head injury (full–2015)
http://jcb.sagepub.com/content/35/3/443.long
Correction to – Inhibition of Monoacylglycerol Lipase Prevents Chronic Traumatic Encephalopathy-Like Neuropathology in a Mouse Model of Repetitive Mild Closed Head Injury (full–2015) http://jcb.sagepub.com/content/35/4/706


CIDS/CNS INJURY-INDUCED IMMUNODEFICIENCY SYNDROME
Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24702836
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26999797


CIRCADIAN RHYTHM
Regulation of the Hypothalamic-Pituitary-Adrenal Axis Circadian Rhythm by Endocannabinoids Is Sexually Diergic (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964781/?tool=pmcentrez
Cannabinoids Excite Circadian Clock Neurons (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927117/?tool=pmcentrez
CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846762/
Endocannabinoid signalling: has it got rhythm? (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931554/
An endocannabinoid system is localized to the hypophysial pars tuberalis of Syrian hamsters and responds to photoperiodic changes (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20165884
top

Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic
modulation (abst–2010)  http://www.sciencedirect.com/science/article/pii/S1043661810000241
Ghrelin-mediated appetite regulation in the central nervous system (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21524673
The emerging role of the endocannabinoid system in the sleep-wake cycle modulation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21919868
Photoperiodic Changes in Endocannabinoid Levels and Energetic Responses to Altered
Signalling at CB1 Receptors in Siberian Hamsters (full–2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060156/
Chronic administration of THC prevents the behavioral effects of intermittent adolescent
MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity
in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189263/
Does the neuroprotective role of anandamide display diurnal variations? (full–2013) http://www.mdpi.com/1422-0067/14/12/23341/htm
Brain Region-Specific Changes in N-Acylethanolamine Contents with Time of Day (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12495/full
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and
mood in rats (abst–2013)  http://www.sciencedirect.com/science/article/pii/S009130571300097X
Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol (full–2014) http://press.endocrine.org/doi/10.1210/jc.2014-3455?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
When time stands still: an integrative review on the role of chronodisruption in
posttraumatic stress disorder (full–2014) https://escholarship.org/uc/item/26d306vj
Multiple sleep alterations in mice lacking cannabinoid type 1 receptors (full–2014)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0089432
2-Arachidonoyl glycerol sensitizes the pars distalis and enhances forskolin-stimulated prolactin secretion in Syrian hamsters (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24200164
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid
2-arachidonoylglycerol (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763355/
The effects of chronic marijuana use on circadian entrainment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801606
Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure (full–2016) http://iovs.arvojournals.org/article.aspx?articleid=2588572
Disturbances of sleep and circadian rhythms: novel risk factors for obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27584008
Endocannabinoids and sleep (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0149763416302640
Signaling pathways to and from the hypophysial pars tuberalis, an important center for
the control of seasonal rhythms (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/28511899
Daytime-Dependent Changes of Cannabinoid Receptor Type 1 and Type 2 Expression in
Rat Liver (full–2017) http://www.mdpi.com/1422-0067/18/9/1844/htm
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653665
The excitatory/inhibitory input to orexin/hypocretin neuron soma undergoes day/night
reorganization (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28669028
The effects of anandamide and oleamide on cognition depend on diurnal variations  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28789932


CLINICAL ENDOCANNABINOID DEFICIENCY THEORY
Irritable bowel syndrome: a dysfunction of the endocannabinoid system? (full–2012)  http://www.gastrojournal.org/article/S0016-5085%2811%2901710-0/fulltext
Endocannabinoid receptor (CB1R) deficiency affects maternal care and alters the dam’s
hippocampal oxytocin receptor and BDNF expression (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23895426
Clinical endocannabinoid deficiency (CECD) revisited: can this concept explain the
therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24977967
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity (full–2016) http://www.medical-hypotheses.com/article/S0306-9877(16)30280-8/fulltext
The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two
Recent Genetic Endocannabinoid Deficiency Models (article–2016)  http://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00532-6/fulltext
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are
associated with neurological phenotypes in humans (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187926
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28745306


CNS/CENTRAL NERVOUS SYSTEM
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00144.x/full
NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System  (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033984/
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss  (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871326/
The Effects of Rimonabant on Brown Adipose Tissue in Rat: Implications for Energy
Expenditure (full-2010) http://onlinelibrary.wiley.com/doi/10.1038/oby.2008.509/full
Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001217/?tool=pubmed
Central and peripheral consequences of the chronic blockade of CB1 cannabinoid
receptor with rimonabant or taranabant (full–2010)  http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.06549.x/full
CB2: a cannabinoid receptor with an identity crisis (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931549/?tool=pubmed
Control of bone remodeling by nervous system. Nervous system and bone (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21123931
In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model
of Parkinson’s disease (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20026090
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388033/
The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous system (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729352/
Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice (full–2011) http://link.springer.com/article/10.1007%2Fs00125-011-2082-z
Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice  implications (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188826/?tool=pubmed
Cannabinoid receptor expression in HIV encephalitis and HIV-associated  neuropathologic comorbidities (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135748/
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137183/?tool=pubmed
Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain  (full–2011) http://europepmc.org/articles/PMC3157548
Greasing the wheels of managing overweight and obesity with omega-3 fatty acids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210336/
Multiple Changes in Peptide and Lipid Expression Associated with Regeneration in the
Nervous System of the Medicinal Leech (full–2011)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081291/
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
Ghrelin-mediated appetite regulation in the central nervous system (abst–2011) http://www.sciencedirect.com/science/article/pii/S0196978111001586
Cannabinoids Inhibit Migration of Microglial-like Cells to the HIV Protein Tat (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21735070
Therapeutic potential of the endocannabinoid system in perinatal asphyxia (abst in English–2011) http://www.ncbi.nlm.nih.gov/pubmed/22127663 (abst in Spanish) https://www.neurologia.com/articulo/2011157
Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol (abst–2011) http://onlinelibrary.wiley.com/doi/10.1002/biof.131/abstract
GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525861/
Review article: Endocannabinoids in neuroendopsychology: multiphasic control of
mitochondrial function (full–2012)  http://rstb.royalsocietypublishing.org/content/367/1607/3342.full?sid=dd42995f-c629-4f8c-86a0-5e962e352fda
Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and
restores basal cytokine levels (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603341/
Off-Target Cannabinoid Effects Mediated by GPR55 (full–2012)  https://www.karger.com/Article/FullText/336872
Synaptic Targets of Δ9-Tetrahydrocannabinol in the Central Nervous System (full–2012) http://perspectivesinmedicine.cshlp.org/content/early/2012/12/03/cshperspect.a012237.long
Phytocannabinoids as novel therapeutic agents in CNS disorders (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21924288
The Atypical Cannabinoid O-1602: Targets, Actions, and the Central Nervous System (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22831390
Discovery of agonists of cannabinoid receptor 1 with restricted CNS penetration aimed for treatment of gastroesophageal reflux disease (abst–2012) http://pubs.acs.org/doi/abs/10.1021/jm301511h
Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized controlled Trial Results (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22367503
Sniffing out pharmacology: interactions of drugs with human olfaction (abst–2012) http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147(12)00016-8
Parsing the players: 2-AG synthesis and degradation in the CNS (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12411/full
Surinabant, a selective CB(1) antagonist, inhibits THC-induced central nervous system and heart rate effects in humans (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703229/
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730365/
Multiple sclerosis and the blood-central nervous system barrier (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and
management (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706254/
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and
immune cell accumulation in the CNS (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906668/
Role of the Endocannabinoid System in the Central Regulation of Nonmammalian
Vertebrate Reproduction (full–2013) http://www.hindawi.com/journals/ije/2013/941237/
Differential modulation of nociceptive versus non-nociceptive synapses by
endocannabinoids (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693973/
Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial
Phenotypical Changes in Mice (link to PDF–2013)  http://www.eurekaselect.com/107975/article
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF-2013) http://www.eurekaselect.com/107976/article
Involvement of nitric oxide through endocannabinoids release in microglia activation during the course of CNS regeneration in the medicinal leech (link to PDF–2013) http://citeseerx.ist.psu.edu/viewdoc/summary? doi=10.1.1.718.5567&rank=89&q=cannabinoid&osm=&ossid=
The CB1 cannabinoid receptor mediates glucocorticoid-induced effects on behavioural
and neuronal responses during lactation (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23417606
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation  (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24076098
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and
cytokine release plasticity: implications for signaling at GPR18 (full-2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency
syndrome (full–2014) http://www.medical-hypotheses.com/article/S0306-9877(14)00117-0/fulltext
Endocannabinoid system and pain: an introduction (full–2014)  https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/endocannabinoid-system-and-pain-anintroduction/4C5678CCAD813D1C978C676155E9E39D/core-reader
Cannabinoids, endocannabinoids and stress (abst–2014)  http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch5/summary
Genetic dissection of the endocannabinoid system and how it changed our knowledge of
cannabinoid pharmacology and mammalian physiology (abst–2014)  http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch4/summary
Components of the endocannabinoid and dopamine systems are dysregulated in
Huntington’s disease: analysis of publicly available microarray datasets (full-2015)  http://onlinelibrary.wiley.com/doi/10.1002/prp2.104/full
cnrip1 is a regulator of eye and neural development in Xenopus laevis (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/gtc.12225/full
An Introduction to the Endogenous Cannabinoid System (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789136/
In vitro opioid receptor affinity and in vivo behavioral studies of Nelumbo nucifera
flower (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636954/
Gastric mucosal protection: from the periphery to the central nervous system (full–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf
Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26238742
Distribution of the Endocannabinoid System in the Central Nervous System (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_3
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25819934
Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815001136
Peripherally Restricted Cannabinoids for the Treatment of Pain (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26497478
Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide
synthase in rat brain hippocampus (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26115586
Endocannabinoids drive the acquisition of an alternative phenotype in microglia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26086345
The Endocannabinoid Signaling System in the CNS: A Primer (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26638763
Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25615413
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/cns.12506/full
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review (full–2016) http://link.springer.com/article/10.1007%2Fs12035-016-0313-5
A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid
and cannabinoid systems (full–2016)  https://jvat.biomedcentral.com/articles/10.1186/s40409-016-0091-6
Phytocannabinoids and cannabimimetic drugs: recent patents in central nervous system disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27184693
Synthetic cannabinoid receptor agonists and antagonists: implication in CNS disorders. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27193072
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26999797
Cannabinoid receptor ligand bias: implications in the central nervous system (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27835801
Advances in the Physiology of GPR55 in the Central Nervous (abst–2016)  http://www.eurekaselect.com/144395/article
The central cannabinoid receptor type-2 (CB2) and chronic pain (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27842450
Dangerous drugs: products containing synthetic chemicals (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26915246
The Central Nervous System and Bone Metabolism: An Evolving Story (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27501818
Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334611
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in
Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fncel.2016.00294/full
Altered striatal endocannabinoid signaling in a transgenic mouse model of
spinocerebellar ataxia type-3 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407801/
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and
peripheral nervous system (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181064
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531370/
The role of the endocannabinoid system in the antihyperalgesic effect of Cedrus atlantica
essential oil inhalation in a mouse model of postoperative pain (full–2017)  http://www.sciencedirect.com/science/article/pii/S0378874117320172?via%3Dihub
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis
Pathophysiology? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337874/
(-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor
Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412277/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders (full–2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues
for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Dual Influence of Endocannabinoids on Long-Term Potentiation of Synaptic
Transmission (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742107/
Delirium and High Creatine Kinase and Myoglobin Levels Related to Synthetic
Cannabinoid Withdrawal (link to full–2017)  https://www.hindawi.com/journals/crim/2017/3894749/
CB1 Receptors Signaling in the Brain: Extracting Specificity from Ubiquity (link to PDF–2017) http://www.nature.com/npp/journal/vaop/naam/abs/npp2017206a.html?foxtrotcallback=true
CRIP1a inhibits endocytosis of G-protein coupled receptors activated by
endocannabinoids and glutamate by a common molecular mechanism (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28295323
Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic
Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28397128
Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2
expression in a transgenic mouse model of Alzheimer’s disease (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28551012
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA
10-2474 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28596366
Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine  densities in brain regions important to zebra finch vocal learning and production in an
antidepressant-sensitive manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28743448
Chapter Eleven – Is the Cannabinoid CB2 Receptor a Major Regulator of the  Neuroinflammatory Axis of the Neurovascular Unit in Humans? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1054358917300376?via%3Dihub
Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014488617302212
Managing neuropathic pain in multiple sclerosis: Pharmacological interventions (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28875858
Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in
inflammatory pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28879802
Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain
injury to optimize and facilitate clinical translation (abst–2017)  http://www.sciencedirect.com/science/article/pii/S014976341730088X
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly
selective fatty acid amide hydrolase inhibitor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29017758
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor Independent Mechanisms (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29066974
Acute side effects after consumption of the new synthetic cannabinoids ABCHMINACA  and MDMB-CHMICA (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29072524
Endocannabinoid-Mediated Potentiation of Non-Nociceptive Synapses Contributes to
Behavioral Sensitization (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29118192
Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor
Expression in the Brains of Dams but Not Their Offspring (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29131068
Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic  hippocampal neurons (abst–2017)  http://www.sciencedirect.com/science/article/pii/S104366181730871X?via%3Dihub
Neuroprotective effects of drug-induced therapeutic hypothermia in central nervous
system diseases (abst–2017) http://www.eurekaselect.com/152965/article
A Review of Adjunctive CNS Medications Used for the Treatment of Post-Surgical Pain  (abst–2017) https://link.springer.com/article/10.1007%2Fs40263-017-0440-1
Hunger, ghrelin and the gut (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0006899318300386


COCAINE and the ENDOCANNABINOID SYSTEM
Adolescent cannabis use increases risk for cocaine-induced paranoia (full-2010)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821949/pdf/nihms156770.pdf
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance  Exposure (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?tool=pubmed
Zinc Reduces the Detection of Cocaine, Methamphetamine, and THC by ELISA Urine
Testing (We need 8 to 11 mg of zinc daily; over 40 mg/day can cause nausea and zinc poisoning ) (full–2011) http://jat.oxfordjournals.org/content/35/6/333.long
Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity
in adolescent but not adult male rats (full–2011)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242894/
Brain cannabinoid CB2 receptors modulate cocaine’s actions in mice (full–2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164946/
Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice  implications (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188826/?tool=pubmed
Effect of substance abuse on defibrillation threshold in patients with implantable
cardioverter-defibrillator (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022948/
Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21330091
Alcohol, psychoactive drugs and fatal road traffic accidents in Norway: a case-control
study (abst–2011) http://www.sciencedirect.com/science/article/pii/S0001457510004112?via%3Dihub
Substance use disorders in the U.S. Armed Forces, 2000-2011 (abst–2012)
http://www.ncbi.nlm.nih.gov/pubmed/23231051
Predictors of stigmatization towards use of various illicit drugs among emerging adults  (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23061324
Further evidence for association of polymorphisms in the CNR1 gene with cocaine  addiction: confirmation in an independent sample and meta-analysis (full–2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223560/
Probability and predictors of transition from abuse to dependence on alcohol, cannabis,
and cocaine: results from the national epidemiologic survey on alcohol and related  conditions (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755735/
Single doses of THC and cocaine decrease proficiency of impulse control in heavy
cannabis users (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12425/full
Elevated urine zinc concentration reduces the detection of methamphetamine, cocaine,
THC and opiates in urine by EMIT (full–2013) (Adults need 8 to 11 mg of zinc daily; over 40 mg/day can cause nausea and zinc poisoning )
http://jat.oxfordjournals.org/content/37/9/665.full
Dysregulation of Cannabinoid CB1 Receptor and Associated Signaling Networks in Brains of Cocaine Addicts and Cocaine-Treated Rodents (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23727505
Determination of cocaine, cocaine metabolites and cannabinoids in single hairs by  MALDI Fourier transform mass spectrometry – preliminary results (abst–2013)
http://www.ncbi.nlm.nih.gov/pubmed/23386550
Simultaneous Quantification of Cocaine, Amphetamines, Opiates and Cannabinoids in
Vitreous Humor (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24225634
Cocaine-Induced Behavioral Sensitization Is Associated With Changes in the Expression  of Endocannabinoid and Glutamatergic Signaling Systems in the Mouse Prefrontal  Cortex (full–2014) http://ijnp.oxfordjournals.org/content/18/1/pyu024.long
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self Administration in Mice and Rats (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330519/
Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on  reinstatement of cocaine- and methamphetamine-seeking behavior in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161648/
A One-Step Extraction Procedure for the Screening of Cocaine, Amphetamines and
Cannabinoids in Postmortem Blood Samples (full–2014)  https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bku039
Concordance of self-reported drug use and saliva drug tests in a sample of emergency
department patients (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120967/
Cocaine’s fall and marijuana’s rise: questions and insights based on new estimates of  consumption and expenditures in US drug markets (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25039446
Workplace drug testing in Italy: Findings about second-stage testing (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24652693
Cocaine-induced endocannabinoid release modulates behavioral and neurochemical
sensitization in mice (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913738/
Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900926-2
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in  rats (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703460/
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (full–2015) http://www.hindawi.com/journals/mi/2015/523418/
Enhancement of endocannabinoid signalling protects against cocaine-induced  neurotoxicity (full–2015)  http://www.sciencedirect.com/science/article/pii/S0041008X15001556
Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits
potential of cannabinoids for crack-cocaine use (full–2015)  http://www.ijdp.org/article/S0955-3959(15)00300-X/fulltext
Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice:
Possible role of the mTOR pathway and reduction in glutamate release (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0161813X15001229
Comprehensive monitoring of the occurrence of 22 drugs of abuse and transformation
products in airborne particulate matter in the city of Barcelona (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0048969715302254
Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding
Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait.
(full – 2016) http://www.hindawi.com/journals/np/2016/6481862/
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid mediated disinhibition of dopaminergic neurons (full–2016)  http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via
Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats (full–2016) http://ijnp.oxfordjournals.org/content/early/2016/12/19/ijnp.pyw102.long
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a  comprehensive review (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845302/
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food
reward in male mice (full-2016) http://www.ncbi.nlm.nih.gov/pubmed/26873082
Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27624146
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of
rats treated with cocaine during adolescence (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/26797579
Estradiol impacts the endocannabinoid system in female rats to influence behavioral and
structural responses to cocaine (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0028390816302428
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid  signaling-related proteins in the mouse hippocampus (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26811312
Influence of thermal hair straightening on cannabis and cocaine content in hair (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26826847
Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine
Withdrawal Symptoms in Adult Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486147/
Psychostimulant Effect of the Synthetic Cannabinoid JWH-018 and AKB48: Behavioral,
Neurochemical, and Dopamine Transporter Scan Imaging Studies in Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543288/
CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-
Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice (full–2017)  https://www.nature.com/articles/s41598-017-12399-z
The Epac-phospholipase Cε pathway regulates endocannabinoid signaling and cocaine induced disinhibition of VTA dopamine neurons (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354337/
Post-sensitization treatment with rimonabant blocks the expression of cocaine-induced
behavioral sensitization and c-Fos protein in mice (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0091305717301995?via%3Dihub
Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28399488
Cannabis and cue-induced craving in cocaine-dependent individuals: A pilot study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28431292
Epigenetic mechanisms associated with addiction-related behavioural effects of nicotine
and/or cocaine: implication of the endocannabinoid system (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28704272
Demographic and clinical characteristics of treatment seeking women with full and  subthreshold PTSD and concurrent cannabis and cocaine use disorders (abst–2017) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(17)30009-0/fulltext
17β-Estradiol Potentiates the Reinstatement of Cocaine Seeking in Female Rats: Role of
the Prelimbic Prefrontal Cortex and Cannabinoid Type-1 Receptors (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28825421
Occurrence of illicit drugs in water and wastewater, and their removal during wastewater treatment (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0043135417306413
Stress Promotes Drug Seeking Through Glucocorticoid-Dependent Endocannabinoid
Mobilization in the Prelimbic Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29100630
Oral fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29173162


COHORT/LARGE STUDIES
Effects of cannabis on lung function: a population-based cohort study (full-2010) http://erj.ersjournals.com/content/35/1/42.long
Evaluating the drug use “gateway” theory using cross-national data: Consistency and  associations of the order of initiation of drug use among participants in the WHO World  Mental Health Surveys (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835832/?tool=pubmed
Cannabis and crime: findings from a longitudinal study (abst-2010)  https://www.ncbi.nlm.nih.gov/pubmed/19839964
Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British Cohort Study (full–2011) (must register) http://www.academia.edu/1090026/Intelligence_across_childhood_in_relation_to_illegal_drug_use_in_adulthood_1970_British_Cohort_Study
Cannabis use and Cognitive Function: Eight Year Trajectory in a Young Adult Cohort (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21749524
The expression of the peripheral cannabinoid receptor CB2 has no effect on clinical  outcome in diffuse large B-cell lymphomas (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21457344
Marijuana use among older adults in the U.S.A.: user characteristics, patterns of use, and
implications for intervention (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21108863
Posttraumatic stress disorder and Cannabis use in a nationally representative sample  (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480682
Alcohol and cannabis abuse/dependence symptoms and life satisfaction in young
adulthood (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21733007
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts (full–2012) http://www.biomedcentral.com/1471-244X/12/112
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years (full–2012) http://jama.jamanetwork.com/article.aspx?articleid=1104848
Decreased prevalence of diabetes in marijuana users: cross-sectional data from the
National Health and Nutrition Examination Survey (NHANES) III (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289985/
Sex differences in the cumulative incidence of substance use by birth cohort (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23200762
An age–period–cohort analysis of cannabis use prevalence and frequency in Germany, 1990–2009 (abst–2012) http://jech.bmj.com/content/early/2011/10/20/jech-2011-200180
The changing demographic of blunt smokers across birth cohorts (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23201173
Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV-Hepatitis C Coinfection: A Longitudinal Cohort Analysis (full–2013)
http://cid.oxfordjournals.org/content/early/2013/07/03/cid.cit378.long
Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status (full–2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600466/
Synthetic cannabis: A comparison of patterns of use and effect profile with natural  cannabis in a large global sample (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23291209
The Relationship Between Subjective Experiences During First Use of Tobacco and  Cannabis and the Effect of the Substance Experienced First (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23929590
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based  on NHANES 2005–2010 (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297696/
A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676097/
METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523241/
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH) (full–2015)
http://cid.oxfordjournals.org/content/61/1/40.long
K2 and Spice use among a cohort of college students in southeast region of the USA (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526379/
Adolescent cannabis and tobacco use and educational outcomes at age 16: birth cohort
study (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405050/
Prevalence of Marijuana and Other Substance Use Before and After Washington State’s
Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana:
Cohort Comparisons in a Sample of Adolescents (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744815/
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the  California Men’s Health Study (full–2015) http://www.goldjournal.net/article/S0090-4295(14)01206-0/fulltext
Who receives cannabis use offers: A general population study of adolescents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26433564
Association between marijuana use and adverse obstetrical and neonatal outcomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26401751
Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26233612
Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis
Spasticity in Italy: First Data from a Large Observational Study (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26571097
Marijuana use and pregnancy: prevalence, associated characteristics, and birth  outcomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25895138
Maternal marijuana use and neonatal morbidity (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26026918
Assessing the overlap between tobacco and marijuana: Trends in patterns of co-use of
tobacco and marijuana in adults from 2003-2012 (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26036666
top
Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study (full–2016) http://jop.sagepub.com/content/early/2016/01/06/0269881115622241.full
Trends in cannabis use disorders among racial/ethnic population groups in the United States (full–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30147-8/fulltext
Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women (full–2016) https://www.hindawi.com/journals/jdr/2016/6278709/
Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13645/full
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45 000 Swedish Men (full–2016)  http://stroke.ahajournals.org/content/48/2/265.long
Marijuana users do not have increased healthcare utilization: A National Health and
Nutrition Examination Survey (NHANES) study (1st page–2016)  http://www.ejinme.com/article/S0953-6205(16)30231-X/fulltext
The old open question of marijuana and healthcare: Flares from NANHES (1st page–2016) http://www.ejinme.com/article/S0953-6205(16)30256-4/fulltext
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015 (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30215-0/fulltext
Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27750184
Identifying HIV care enrollees at-risk for cannabis use disorder (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28006972
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26820826
Childhood academic ability in relation to cigarette, alcohol and cannabis use from  adolescence into early adulthood: Longitudinal Study of Young People in England  (LSYPE) (full–2017) http://bmjopen.bmj.com/content/7/2/e012989.long
Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian
cohort of 614 patients (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449133/
Patterns of cannabis use during adolescence and their association with harmful substance use behaviour: findings from a UK birth cohort (full–2017)  http://jech.bmj.com/content/71/8/764
Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana (full–2017) http://pediatrics.aappublications.org/content/139/4/e20162675.long
Associations between Cannabis Use and Physical Health Problems in Early Midlife: A
Longitudinal Comparison of Persistent Cannabis versus Tobacco Users (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936934/
Synthetic Cannabinoid Use Among High School Seniors (full–2017)  http://pediatrics.aappublications.org/content/early/2017/09/07/peds.2017-1330.long
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A
cross-sectional study (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176416
Cannabis, alcohol and fatal road accidents (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678710/
Frequency of Cannabis Use Among Primary Care Patients in Washington State (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769869/
Recreational Marijuana Use and Acute Myocardial Infarction: Insights from Nationwide
Inpatient Sample in the United States (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752226/
Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders (1st page–2017) http://jamanetwork.com/journals/jama/article-abstract/2610319
Modelling possible causality in the associations between unemployment, cannabis use,
and alcohol misuse (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0277953617300011
Whole genome sequence study of cannabis dependence in two independent cohorts  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28111843
Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community
Sample With American Indians (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28117058
Cannabis use and the course and outcome of major depressive disorder: A population  based longitudinal study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31187-8/abstract
Cannabis use and mental health-related quality of life among individuals with depressive disorders (abst–2017) http://www.psy-journal.com/article/S0165-1781(15)30306-1/fulltext
Marijuana Use and Self-reported Quality of Eyesight (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28422803
Evidence for Sex Convergence in Prevalence of Cannabis Use: A Systematic Review and
Meta-Regression (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28499099
Early cannabis initiation and educational attainment: is the association causal? Data from the French TEMPO study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28520946
Examination of cumulative effects of early adolescent depression on cannabis and  alcohol use disorder in late adolescence in a community-based cohort (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28600897
Substantiated childhood maltreatment and young adulthood cannabis use disorders: A
pre-birth cohort study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31722-X/fulltext
Associations between Adolescent Cannabis Use and Neuropsychological Decline: A

Longitudinal Co-Twin Control Study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28734078
Cognitive Functioning of Adolescent and Young Adult Cannabis Users in the Philadelphia Neurodevelopmental Cohort (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28414475
Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with
acute recreational drug toxicity to an Emergency Department in London, UK in the first
half of 2015 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28421836
Marijuana and tobacco co-use among a nationally representative sample of US pregnant
and non-pregnant women: 2005-2014 National Survey on Drug Use and Health findings  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599211
Predicting Persistent, Limited, and Delayed Problematic Cannabis Use in Early  Adulthood: Findings From a Longitudinal Study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29096779
Marijuana use during pregnancy: A comparison of trends and correlates among married
and unmarried pregnant women (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30531-8/fulltext
Association Between Marijuana Use and Sexual Frequency in the United States: A  Population-Based Study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29110804
Associations between medical cannabis and other drug use among unstably housed
women (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29227883
Patterns of simultaneous and concurrent alcohol and marijuana use among adolescents  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29261344
Is recovery from cannabis use problems different from alcohol and other drugs? Results  from a national probability-based sample of the United States adult population (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29287223
Marijuana use among adults: Initiation, return to use, and continued use versus quitting
over a one-year follow-up period (full–2018)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30535-5/fulltext
Increased Levels of Circulating Fatty Acids Are Associated with Protective Effects against Future Cardiovascular Events in Nondiabetics (abst–2018)  http://pubs.acs.org/doi/10.1021/acs.jproteome.7b00671
Does Marijuana Use at Ages 16-18 Predict Initiation of Daily Cigarette Smoking in Late
Adolescence and Early Adulthood? A Propensity Score Analysis of Add Health Data (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29388049


COLITIS*+
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn’s Disease (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829088/?tool=pmcentrez
Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis (full–2010) http://www.jpp.krakow.pl/journal/archive/02_10/pdf/89_02_10_article.pdf
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?tool=pubmed
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice (full–2010) http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00132/full
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice (full–2010) http://jpet.aspetjournals.org/content/334/3/973.long
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116968/
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?tool=pubmed
β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070571/
Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117838/
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21876860
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation (full–2011) http://www.fasebj.org/content/25/8/2711.long
The endogenous cannabinoid system in the gut of patients with inflammatory bowel
disease (full–2011) http://www.nature.com/mi/journal/v4/n5/full/mi201118a.html
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in
health and disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624216/
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related
systemic inflammation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21551239
Cannabis use amongst patients with inflammatory bowel disease (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21795981
Role of cannabinoid receptors and RAGE in inflammatory bowel disease (abst–2011)
http://www.unboundmedicine.com/medline/ebm/record/21472688/abstract/Role_of_cannabinoid_receptors_and_RAGE_in_inflammatory_bowel_disease_
The JNK inhibitor XG-102 protects against TNBS-induced colitis (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302790/
Gut microbiota and the development of obesity (full–2012) http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000500007&lng=en&nrm=iso&tlng=en
The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model (full–2012) http://www.biomedcentral.com/content/pdf/2050-6511-13-S1-A23.pdf
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice (full–2012) http://content.karger.com/produktedb/produkte.asp?DOI=000336871&typ=pdf
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22917662
4-Oxo-1,4-dihydropyridines as Selective CB2 Cannabinoid Receptor Ligands Part 2: Discovery of New Agonists Endowed with Protective Effect Against Experimental Colitis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23017078
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22815234
Role of endogenous cannabinoid system in the gut (full–2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
top

O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529923/
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract (full–2013) http://www.jpp.krakow.pl/journal/archive/04_13/pdf/167_04_13_article.pdf
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis (full–2013) http://www.nature.com/labinvest/journal/v93/n3/full/labinvest2012177a.html
Marijuana use patterns among patients with inflammatory bowel disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24185313
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model (abst–2013)  http://www.sciencedirect.com/science/article/pii/S1043466613007345
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the  treatment of pain and inflammatory diseases in the gastrointestinal tract (abst–2013)  http://www.sciencedirect.com/science/article/pii/S092809871300451X
Prostaglandin ethanolamides attenuate damage in a human explant colitis model (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23380599
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454360
Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23706402
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23849204
The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650567/
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12907/full
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon Npalmitoylethanolamine levels and counteracts murine colitis (full–2014)
http://www.fasebj.org/content/29/2/650.long
IBD patients find symptom relief in the Cannabis field (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947743/
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at
Central and Peripheral Receptors (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183544/
Medical Marijuana for Digestive Disorders: High Time to Prescribe? (1st page–2014) (needs registration) http://www.medscape.com/viewarticle/839801 (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/25199471
Switching cannabinoid response from CB2 agonists to FAAH inhibitors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508127
Colitis generates remote antinociception in rats: the role of the Larginine / NO / cGMP / PKG / KATP pathway and involvement of cannabinoid and opioid systems (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25286904
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.12907/full
GPR55 – a putative “type 3” cannabinoid receptor in inflammation (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0080/jbcpp-2015-0080.xml
Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556478/
The GPR55 antagonist CID16020046 protects against intestinal inflammation (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587547/
Gastric mucosal protection: from the periphery to the central nervous system (full–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf
top
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25699149
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment (full–2016) http://journal-inflammation.biomedcentral.com/articles/10.1186/s12950-016-0129-0
Endocannabinoids in the Gut (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940133/
The CB2 receptor and its role as a regulator of inflammation (full–2016) http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK (full–2016) http://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse (full-2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047908/
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017608/
Therapeutic Use of Cannabis in Inflammatory Bowel Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/
Role of cannabinoids in gastrointestinal mucosal defense and inflammation (abst–2016) http://www.eurekaselect.com/140045/article
Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization? (link to PDF–2016) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4045
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27327245
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26561079 Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27875353
Application of carbon nanotubes as the carriers of the cannabinoid, 2- arachidonoylglycerol: Towards a novel treatment strategy in colitis (abst–2016) http://www.sciencedirect.com/science/article/pii/S002432051630666X
The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis (abst–2016) http://link.springer.com/article/10.1007%2Fs10620-016-4404-y
We are not alone: a case for the human microbiome in extra intestinal diseases (full–2017) https://gutpathogens.biomedcentral.com/articles/10.1186/s13099-017-0163-3
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process
induced by Clostridium difficile toxin A in Caco-2 cells (full–2017)  http://journals.sagepub.com/doi/full/10.1177/2050640617698622
Host-probiotic interaction: new insight into the role of the endocannabinoid system by in
vivo and ex vivo approaches (full–2017) https://www.nature.com/articles/s41598-017-01322-1
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we  go? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/
Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-
Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis
Extracts (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627671/
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process
induced by Clostridium difficile toxin A in Caco-2 cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721977/
Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid  system protects against colitis and ameliorates remote organ lesions in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740744/
G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn’s  disease and ulcerative colitis (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/00365521.2017.1298834?journalCode=igas20


CONSTIPATION +
Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional  constipation (abst–2011) https://www.ncbi.nlm.nih.gov/pubmed/21045817
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted
from Cannabis sativa, on inflammation-induced hypermotility in mice (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417459/
Agents that act luminally to treat diarrhoea and constipation (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22945441
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study (full–2013)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085073
Effect of high fat-diet and obesity on gastrointestinal motility (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890396/
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic
Inertia in Slow Transit Constipation (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23926887
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of  constipation (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459026/


COPD/CHRONIC OBSTRUCTIVE PULMONARY DISEASE*+
Effects of cannabis on lung function: a population-based cohort study (full–2010) http://erj.ersjournals.com/content/35/1/42.long
Does cannabis use predispose to chronic airflow obstruction? (full–2010) http://erj.ersjournals.com/content/35/1/3.full?ijkey=d1405bb2fc0ed2aff675335858f284f7f470fbbc&keytype2=tf_ipsecsha
Effects of smoking cannabis on lung function (full–2011) http://www.expert-reviews.com/doi/full/10.1586/ers.11.40
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety (abst–2011) http://crd.sagepub.com/content/early/2011/01/23/1479972310391283.abstract
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21056512
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years (full–2012) http://jama.jamanetwork.com/article.aspx?articleid=1104848
Effects of marijuana smoking on the lung (full–2013) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201212-127FR#.U903xGN8E24
Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88-2003&rfr_idri:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
Health outcomes associated with long-term regular cannabis and tobacco smoking (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23501136
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/2446741
Effects of Marijuana Exposure on Expiratory Airflow: A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study (full–2014)  http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201407-333OC#.VrA9xVJA44A
Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25356537
Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25624312
top

Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup  (full-2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655949
How beneficial is vaping cannabis to respiratory health compared to smoking? (article-2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs? (full–2016) http://www.jleukbio.org/content/99/4/518.full
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26808080
Cannabis and lung. What we know and everything we don’t know yet (abst in English & French-2017) http://www.em-consulte.com/article/1173971/alertePM


CORNEAL KERATITIS
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00304/full


COUGH +
G-protein coupled receptors regulating cough (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21727026
Inhibition Of Fatty Acid Amide Hydrolase Produces Anti-Tussive Effects In Guinea-Pigs: Evidence For Elevated Fatty Acid Amides Acting Via Cannabinoid Receptors On Airway Sensory Nerves (abst–2012) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A2149
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655949
Effects of quitting cannabis on respiratory symptoms (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780250/
Endocannabinoid Inhibition Of Airway Sensory Nerve Depolarisation (abst–2015)  http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4114
Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28931663


COWPOX
Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21131094/abstract/Cannabinoids_lead_to_enhanced_virulence_of_the_smallpox_vaccine__vaccinia__virus_
“Recreational” drug abuse associated with failure to mount a proper antibody response after a generalised orthopoxvirus infection (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/17917699
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full–2015)
http://www.hindawi.com/journals/mi/2015/349176/


CREATIVITY and CANNABIS
Creativity in cannabis-users and in drug addicts in maintenance treatment and in  rehabilitation (abst in English & German–2013)  https://link.springer.com/article/10.1007%2Fs40211-012-0045-3
Inspired by Mary Jane? Mechanisms underlying enhanced creativity in cannabis users  (abst–2017) https://www.sciencedirect.com/science/article/pii/S1053810017303744?via%3Dihub
A Qualitative Study on the Effects of Psychoactive Substance use upon Artistic
Creativity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29185845


CRIME and CANNABIS
Cannabis and crime: findings from a longitudinal study (abst-2010)  https://www.ncbi.nlm.nih.gov/pubmed/19839964
Exploring the ecological association between crime and medical marijuana dispensaries  (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364319/
Illegal drugs and delinquency (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23434380
The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-
2006 (full–2014)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0092816
Cannabis depenalisation, drug consumption and crime – Evidence from the 2004 cannabis declassification in the UK (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0277953614003621
Drugs and Crime Facts (full–2015) http://www.bjs.gov/content/dcf/ptrpa.cfm
Multidimensional Family Therapy Reduces Self-Reported Criminality Among
Adolescents With a Cannabis Use Disorder (download–2017) http://www.mdft.org/mdft/media/files/Publications/van-der-Pol-et-al-%282017%29-MDFT-reduces-self-criminality-among-adolescents-with-a-cannabis-use-disorder.pdf
Illicit drug policy in Spain: the opinion of health and legal professionals (abst in Spanish, link to PDF in English-2017)  http://www.adicciones.es/index.php/adicciones/article/view/810
Acceptability and effectiveness of a web-based psychosocial intervention among criminal justice involved adults (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28285466


CROHN’S DISEASE*+
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn’s Disease (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829088/?toolmcentrez
The endogenous cannabinoid system in the gut of patients with inflammatory bowel
disease (full–2011) http://www.nature.com/mi/journal/v4/n5/full/mi201118a.html
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in
health and disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624216/
Medical cannabis: the opportunity versus the temptation (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22352284
Cannabis use amongst patients with inflammatory bowel disease (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21795981
Role of cannabinoid receptors and RAGE in inflammatory bowel disease (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21472688/abstract/Role_of_cannabinoid_receptors_and_RAGE_in_inflammatory_bowel_disease_
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility (full–2012) http://content.karger.com/produktedb/produkte.asp?DOI=000339072&typdf
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome (full–2012) http://ajpgi.physiology.org/content/302/10/G1075
Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362100/
top
Gut microbiota and the development of obesity (full–2012) http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000500007&lng=en&nrm=iso&tlng=en
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted
from Cannabis sativa, on inflammation-induced hypermotility in mice (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417459/
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22917662
Cannabis Finds Its Way into Treatment of Crohn’s Disease (full–2013) http://www.karger.com/Article/Pdf/356512
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract (full–2013) http://www.jpp.krakow.pl/journal/archive/04_13/pdf/167_04_13_article.pdf
Cannabis Induces a Clinical Response in Patients with Crohn’s Disease: a Prospective Placebo-Controlled Study (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23648372
Marijuana use patterns among patients with inflammatory bowel disease (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126607/
Industrial hemp decreases intestinal motility stronger than indian hemp in mice (link to PDF–2013) http://www.europeanreview.org/article/3266
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24275607
IBD patients find symptom relief in the Cannabis field (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947743/
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at
Central and Peripheral Receptors (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183544/
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis
Extracts to Treat Diseases (link to upload-2014)  http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement
Medical Marijuana for Digestive Disorders: High Time to Prescribe? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25199471
Cannabis for inflammatory bowel disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24969296
Colitis generates remote antinociception in rats: the role of the L-arginine / NO / cGMP / PKG / KATP pathway and involvement of cannabinoid and opioid systems (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25286904
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/24407485
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26075589
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (abst–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13069/abstract
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26387676
Gastric mucosal protection: from the periphery to the central nervous system (full–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science  (interview–2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lestergrinspoon/
Cannabis – therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26422462
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK (full–2016) http://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm
Therapeutic Use of Cannabis in Inflammatory Bowel Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/
top
Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization? (link to PDF–2016) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4045
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26809974
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27327245
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26561079 Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27875353
Host-probiotic interaction: new insight into the role of the endocannabinoid system by in
vivo and ex vivo approaches (full–2017) https://www.nature.com/articles/s41598-017-01322-1
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we
go? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/
Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-
Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis
Extracts (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627671/
G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn’s
disease and ulcerative colitis (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/00365521.2017.1298834?journalCode=igas20
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn’s Disease, a
Randomized Controlled Trial (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28349233
Role of cannabis in digestive disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/27792038
Systematic review: interventions for abdominal pain management in inflammatory bowel disease (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28470846
Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28981653


CRPS/RSD-COMPLEX REGIONAL PAIN SYNDROME/REFLEX SYMPATHETIC DYSTROPHY/CAUSALGIA +
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643547/
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717112


CULTIVATION
Marijuana Grow Bible (download-undated)  http://www.ilovegrowingmarijuana.com/marijuana-grow-bible/
The Cannabis Grow Bible (book-undated) http://www.kindgreenbuds.com/cannabis-grow-bible/
Observations on the raising and dressing of hemp (1789) As text –  http://memory.loc.gov/cgi-bin/query/r?ammem/faw:@field%28DOCID+icufawcbc0010%29
Observations on the raising and dressing of hemp (1789) Original format – http://tinyurl.com/h323snn
YEARBOOK OF THE UNITED STATES DEPARTMENT OF AGRICULTURE–1913, pages 283-346. (exerpt–1913) http://www.hempline.com/hemp/hemp_articles/?Article_ID=22
Influence of Environment on Sexual Expression in Hemp (1923)  http://www.jstor.org/stable/2469863?seq=1#page_scan_tab_contents
CARBOHYDRATE-NITROGEN RATIOS WITH RESPECT TO THE SEXUAL EXPRESSION OF HEMP (1934) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC439101/
TIME FACTOR IN UTILIZATION OF MINERAL NUTRIENTS BY HEMP by Sister Mary Etienne Tibeau (1936) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=439254
GROWTH RESPONSES OF HEMP TO DIFFERENTIAL SOIL AND AIR TEMPERATURES (full–1944) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438156/
Problems of modern hemp breeding, with particular reference to the breeding of varieties of hemp containing little or no hashish (full–1956) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1956-01-01_3_page007.html
Auxin and Sexuality in Cannabis sativa (1st page–1956) http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3054.1956.tb07821.x/abstract
Suppressive Effects of 2-thiouracil on Differentiation and Flowering in Cannabis Sativa (abst–1960) http://www.ncbi.nlm.nih.gov/pubmed/13713898
Induction of female flowers on male plants of Cannabis sativa L. by 2-chloroethanephosphonic acid (download-1970) http://repository.ias.ac.in/26409/1/401.pdf
Feminization of male flowers of Cannabis sativa L. by a morphactin (download–1971)  http://repository.ias.ac.in/26413/1/406.pdf
Induction of male flowers on female plants of Cannabis sativa by gibberellins and its
inhibition by abscisic acid (full–1972) http://repository.ias.ac.in/26417/1/410.pdf
Effects of Chronic Smoking of Cannabis in Jamaica (download–1972) http://cifas.us/pdf/Comitas%20Pdf%20Files/Long%20Manuscripts/1972%20Effects%20of%20Chronic%20Smoking%20of%20Cannabis%20in%20Jamaica.pdf
Cannabinoid Profile and Elemental Uptake of Cannabis sativa L. as Influenced by Soil Characteristics (full-1975)  http://www.votehemp.com/PDF/Cannabinoid_Profile_and_Elemental_Uptake_of_Cannabis_sativa_L._as_Influenced_by_Soil_Characteristics-1975.pdf
Cannabinoid formation in Cannabis sativa grafted inter-racially, and with two Humulus species (abst-1975) http://www.sciencedirect.com/science/article/pii/0031942275851004
Cannabinoid patterns in seedlings of Cannabis sativa L. and their use in the determination of chemical race (abst–1977) http://www.ncbi.nlm.nih.gov/pubmed/19599
Cannabinoid composition and gland distribution in clone of Cannabis sativa L.
(Cannabaceae) (full–1978) https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1978-01-01_1_page007.html
Comparative effect of silver ion and gibberellic acid on the induction of male flowers on
female Cannabis plants (download–1978) http://repository.ias.ac.in/26407/1/399.pdf
CHEMOTAXONOMY OF CANNABIS 1. CROSSBREEDING BETWEEN CANNABIS SATIVA AND C. RUDERALIS, WITH ANALYSIS OF CANNABINOID CONTENT (full-1978) http://www.cannabase.com/cl/bcga/journals/Beutler1979/Beutler1979.html
nfluence of photoperiodism on cannabinoid content of Cannabis sativa L. (abst–1978) http://www.ncbi.nlm.nih.gov/pubmed/248289
top

An investigation of procedures reported to increase potency of marijuana: a chemical analysis and psychological interpretation (abst–1978) http://www.ncbi.nlm.nih.gov/pubmed/721338
The role of roots in sex expression in hemp plants (abst–1978) http://www.ncbi.nlm.nih.gov/pubmed/24414015
The influence of growth regulators absorbed by the root on sex expression in hemp plants (abst–1978) http://www.ncbi.nlm.nih.gov/pubmed/24414014
The role of leaves in sex expression in hemp and spinach (abst–1979) http://www.ncbi.nlm.nih.gov/pubmed/24408695
Sequential appearance of cannabinoids during seedling development (full–1980) https://www.realhemp.com/marihuana-84/
NEW FOSSIL EVIDENCE FOR THE PAST CULTIVATION AND PROCESSING OF HEMP (CANNABIS SATIVA L.) IN EASTERN ENGLAND (full–1981) http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8137.1981.tb02331.x/epdf
Some features of Cannabis plants grown in the United Kingdom from seeds of known origin (full-1982) https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1982-01-01_1_page005.html
Induction of fertile male flowers in genetically female Cannabis sativa plants by silver nitrate and silver thiosulphate anionic complex (abst–1982)
http://www.ncbi.nlm.nih.gov/pubmed/24270659
Marijuana, Cannabis sativa L: Moraceae, Cannaboideae (full–1983) http://webcache.googleusercontent.com/search?q=cache:msivoHP3z0wJ:www.agriculture.pa.gov/Protect/PlantIndustry/NIPPP/Documents/marijuana %2520article.pdf+&cd=1&hl=en&ct=clnk&gl=us
Structure, development and composition of glandular trichomes of Cannabis (link to PDF–1984) https://www.realhemp.com/mahlberg-cannabis-research/structure-development-and-composition-ofglandular-trichomes-of-cannabis/
Variation in vegetative growth and trichomes in Cannabis sativa L. (Marihuana) in response to enviromental pollution (abst–1984) http://www.osti.gov/scitech/biblio/5904627
UV-B radiation effects on photosynthesis, growth and cannabinoid production of two Cannabis sativa chemotypes (abst–1987) http://onlinelibrary.wiley.com/doi/10.1111/j.1751-1097.1987.tb04757.x/abstract;jsessionid=E27DFF97974EDECC7DCDFFD1EED18D17.d03t03
Histochemical detection of hemp trichomes and their correlation with the THC content (abst-1988) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=2855383&dopt=abstractplus
HEMP AS A CROP FOR MISSOURI FARMERS (full–1991)  http://druglibrary.org/olsen/hemp/crop/hemp-01.html
Male and female plant selection in the cultivation of hemp, and variations in fossil Cannabis pollen representation (link to download-1992) http://journals.sagepub.com/doi/abs/10.1177/095968369200200111
Chemical ecology of Cannabis (full-1994) http://www.hempfood.com/IHA/iha01201.html
Anatomy and Viability of Cannabis sativa Stem Cuttings With and Without Adventitious Roots (abst–1994) http://www.astm.org/DIGITAL_LIBRARY/JOURNALS/FORENSIC/PAGES/JFS13654J.htm
Commercial Hemp Cultivation in Canada “An Economic Justification” (full–1995) http://www.naihc.org/hemp_information/content/dmarcustx.html
A Male-associated Dna Sequence in a Dioecious Plant, Cannabis Sativa L. (abst–1995)  http://www.ncbi.nlm.nih.gov/pubmed/8589931
The Volatile Oil Composition of Fresh and Air-Dried Buds of Cannabis sativa (full–1996) http://www.medicinalgenomics.com/wp-content/uploads/2011/12/cannabis_volatiles.pdf
Cannabis pests (full–1996) http://www.internationalhempassociation.org/jiha/iha03201.html
Immunochemical localization of tetrahydrocannabinol (THC) in cryofixed glandular trichomes of Cannabis (Cannabaceae) (full–1997) http://www.amjbot.org/content/84/3/336.full.pdf+html
Effect of nitrogen on tetrahydrocannabinol (THC) content in hemp (Cannabis sativa L) leaves at different positions (full-1997) http://www.internationalhempassociation.org/jiha/jiha4207.html
Factors influencing the yield and the quality of hemp (Cannabis sativa L.) essential oil (full–1998) http://www.druglibrary.org/olsen/hemp/iha/jiha5107.html
Industrial Hemp as an Alternative Crop in North Dakota (download–1998)  http://www.globalhemp.com/wp-content/uploads/industrial-hemp-as-an-alternative-crop-in-north-dakoda.pdf
Economic Impact of Industrial Hemp in Kentucky (download–1998)  http://www.votehemp.com/PDF/hempstudy.pdf
Feasibility of Industrial Hemp Production in the United States Pacific Northwest (link to PDF–1998) https://catalog.extension.oregonstate.edu/sb681
Agronomic characteristics of some hemp genotypes (full–1999) http://www.druglibrary.org/olsen/hemp/iha/jiha6201.html
Cannabis as an illicit crop: recent developments in cultivation and product quality (full–1999) http://static.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1997-01-01_1_page002.html
Boys and Girls Come Out to Play: The Molecular Biology of Dioecious Plants (link to PDF-2000) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Boys+and+Girls+Come+Out+to+Play%3A+The+Molecular+Biology+of+Dioecious+Plants+%22+&btnG=
Development of a hemp (Cannabis sativa L.) simulation model. 2. The flowering response of two hemp cultivars to photoperiod (abst–2000)
http://cat.inist.fr/?aModele=afficheN&cpsidt=1463824
Cannabis: an environmentally and economically viable method for climate change mitigation (revised 2001) (thesis–2001) http://www.hempreport.com/issues/17/pdf/deeleythesis.pdf
top

Distortion of Teatree Stems by Twine As a Means to Determine the Number of Years That the Stems Have Been Used to Support Cannabis Plants (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11451066
The inheritance of chemical phenotype in Cannabis sativa L. (full-2002) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462421/pdf/12586720.pdf
HISTORICAL AND CULTURAL USES OF CANNABIS AND THE CANADIAN “MARIJUANA CLASH” (full–2002) http://www.parl.gc.ca/content/sen/committee/371/ille/library/spicer-e.htm
The biology of Canadian weeds. 119. Cannabis sativa L. (link to PDF–2003) http://www.nrcresearchpress.com/doi/abs/10.4141/P02-021#.V3IMUqJA76h
Cold – resistance of hemp (Cannabis Sativa L.) (full–2004)  http://vir.nw.ru/hemp/hemp2.htm
US Patent Application 20070151149 – Methods for altering the level of phytochemicals
in plant cells by applying wave lengths of light from 400 nm to 700 nm and apparatus
therefore (full-2004) http://www.freshpatents.com/Methods-for-altering-the-level-of-phytochemicals-in-plant-cells-by-applying-wave-lengths-of-lightfrom-400-nm-to-700-nm-and-apparatus-therefore-dt20070705ptan20070151149.php
Growth characteristics of Cannabis sativa L. cultivated in a phytotron and in the field  (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15940897
Comparing Hemp Seed Yields (Cannabis sativa L.) of an On-Farm Scientific Field Experiment to an On-Farm Agronomic Evaluation Under Organic Growing Conditions in Lower Austria (full–2004) http://tinyurl.com/h33xyjo
Analysis of Heavy Metal Content in Canabis Leaf and Seed Cultivated in Southern Part of Nigeria (full–2005) http://scialert.net/qredirect.php?doi=pjn.2005.349.351&linkid=pdf
Cultivation of Cannabis sativa L. in northern Morocco (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/21338017
Fibre crops as alternative land use for radioactively contaminated arable land (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15795030
The arbuscular mycorrhizal fungus Glomus mosseae induces growth and metal
accumulation changes in Cannabis sativa L. (abst–2005)  http://www.ncbi.nlm.nih.gov/pubmed?term=15698640
Marijuana Production in the United States (full–2006)  http://www.drugscience.org/Archive/bcr2/MJCropReport_2006.pdf
US Patent Application 20060242899 – Method of cultivating plants (full-2006) http://www.freepatentsonline.com/y2006/0242899.html
Seeding rate and row spacing effect on weed competition, yield and quality of hemp in the Parkland region of Saskatchewan (link to PDF–2006) http://www.nrcresearchpress.com/doi/abs/10.4141/P05-177#.V3ILRqJA76h
Yield of illicit indoor cannabis cultivation in the Netherlands (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/17018080
THE EFFECT OF PLANT DENSITY AND NITROGEN FERTILIZER ON LIGHT INTERCEPTION AND DRY MATTER YIELD IN HEMP (CANNABIS SATIVA L.) (abst–2006) http://en.journals.sid.ir/ViewPaper.aspx?ID=102781
Identification and Characterization of Cannabinoids That Induce Cell Death through
Mitochondrial Permeability Transition in Cannabis Leaf Cells (full–2007)  http://www.jbc.org/content/282/28/20739.full?sid=a5db98db-ff96-4187-8790-57097bbe15c1
Dosing Medical Marijuana: Rational Guidelines on Trial in Washington State (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100129/
Apparent increase in biomass and see productivity in hemp (Cannabis sativa) resulting from branch proliferation caused by the European corn borer (Ostrinia nubilalis) (abst–2007) http://www.agr.gc.ca/eng/abstract/?id=9561000000564
Detection method for the ability of hemp (Cannabis sativa L.) seed germination by the use of 2,3,5-triphenyl-2H-tetrazolium chloride (TTC) (full-2008) https://www.jstage.jst.go.jp/article/yakushi/128/11/128_11_1707/_pdf
Effect of Sowing Date on Growth and Development of Thai Hemp (Cannabis sativa L.) (full–2008) http://kasetsartjournal.ku.ac.th/kuj_files/2009/A0908201727458593.pdf
Cannabinoids act as necrosis-inducing factors in Cannabis sativa (full-2008)
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2634471&tool=pmcentrez
Photosynthetic response of Cannabis sativa L. to variations in photosynthetic photon flux densities, temperature and CO2 conditions (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550641/
The cultivation and utilisation of hemp in Scotland (abst–2008) http://www.tandfonline.com/doi/abs/10.1080/00369229018736795?journalCode=rsgj19 Hemp (Cannabis) Cultivation and Use in the Republic of Korea (abst–2008) http://www.tandfonline.com/doi/abs/10.1300/J237v11n01_07?src=recsys
A PROPAGAGATION SYSTEM FOR CLONING OF HEMP (CANNABIS SATIVA L.) BY SHOOT TIP CULTURE (full–2009) http://www.pakbs.org/pjbot/PDFs/41%282%29/PJB41%282%29603.pdf
Propagation through alginate encapsulation of axillary buds of Cannabis sativa L – an important medicinal plant (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550375/
Cannabis Yields and Dosage (full–2009) http://www.chrisconrad.com/pdf/cannayieldsdosage10.pdf
The effect of ultraviolet radiation on the accumulation of medicinal compounds in plants (abst–2009) http://www.sciencedirect.com/science/article/pii/S0367326X09000422
Assessment of Cannabinoids Content in Micropropagated Plants of Cannabis sativa and Their Comparison with Conventionally Propagated Plants and Mother Plant during Developmental Stages of Growth (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19950050
Stable isotope ratios of marijuana. I. Carbon and nitrogen stable isotopes describe growth conditions (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19040673
top

Effects of Gibberellic Acid on Primary Terpenoids and Delta-Tetrahydrocannabinol in Cannabis sativa at Flowering Stage (abst-2009) http://www.unboundmedicine.com/medline/ebm/record/19522814/abstract/Effects_of_Gibberellic_Acid_on_Primary_Terpenoids_and_Delta_Tetrahydrocannabinol_in_Cannabis_sativa_at_Flowering_Stage_
Patterns of Youth Participation in Cannabis Cultivation (abst–2010) http://jod.sagepub.com/content/40/2/263.abstract
N, P, and S fertilization effects on industrial hemp in Saskatchewan (link to PDF 2010) http://www.nrcresearchpress.com/doi/abs/10.4141/CJPS09101#.V3IKF6JA76h
Characteristics of Cannabis sativa L.: seed morphology, germination and growth characteristics, and distinction from Hibiscus cannabinus L (link to PDF–2010) https://www.jstage.jst.go.jp/article/yakushi/130/2/130_2_237/_article
Estimated Cost of Production for Legalized Cannabis (link to PDF–2010)  http://www.rand.org/pubs/working_papers/WR764.html
High Frequency Plant Regeneration from Leaf Derived Callus of High Δ9-Tetrahydrocannabinol Yielding Cannabis sativa L. (abst-2010) https://www.thieme-connect.de/DOI/DOI?10.1055/s-0030-1249773
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers (abst–2010)  https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1185945
The results of an experimental indoor hydroponic Cannabis growing study, using the ‘Screen of Green’ (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20462712
The case for small-scale domestic cannabis cultivation (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20176465
Stable isotope models to predict geographic origin and cultivation conditions of marijuana (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20470741
Propagation of Elite Cannabis sativa for the Production of Δ9-Tetrahydrocannabinol (THC) using Biotechnological Tools (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1251774
Effect of Light Intensity on Photosynthetic Characteristics of High Δ9-THC Yielding Varieties of Cannabis sativa L. (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1251773
Cannabis sativa L. Micropropagation in Temporary Immersion Bioreactor System (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1251771
Hydroponics Cultivation Cannabis sativa L. Plants (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1251772
Variation in Δ9-THC and other Cannabinoids Content in Field Grown Cannabis sativa L During Different Stages of Growth (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1251775
EVALUATION OF GROWTH INDICES OF HEMP (CANNABIS SATIVA L.) AND SESAME (SESAMUM INDICUM L.) IN INTERCROPPING WITH REPLACEMENT AND ADDITIVE SERIES (abst–2010) http://en.journals.sid.ir/ViewPaper.aspx?ID=299367
Photosynthetic response of Cannabis sativa L., an important medicinal plant, to elevated levels of CO2 (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550578/
Temperature response of photosynthesis in different drug and fiber varieties of Cannabis sativa L. (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550580/
top

WITCHES’ BROOM AND PHYLLODY LIKE SYMPTOMS OF DISEASES IN Acalypha indica L. AND Cannabis sativa L. – A NEW REPORT FROM CHAMPARAN, NORTH BIHAR (full–2011) http://www.ijsr.in/upload/805707343Chapter_24.pdf
Characterization of Stolbur (16SrXII) Group Phytoplasmas Associated with Cannabis  sativa Witches’-broom Disease in Iran (full–2011) http://scialert.net/qredirect.php?doi=ppj.2011.161.167&linkid=pdf
Changes of photosynthesis-related parameters and productivity of Cannabis sativa under different nitrogen supply (full–2011) http://eeb.lu.lv/EEB/201108/EEB_9_Malceva.pdf
Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp
(Cannabis sativa L.) (download–2011) http://www.doiserbia.nb.rs/img/doi/0534-0012/2011/0534-00121103449S.pdf
Industrial Hemp (Cannabis sativa L.) – a High-Yielding Energy Crop (thesis–2011) http://pub.epsilon.slu.se/8415/1/prade_t_111102.pdf
Variations in Photosynthesis, Transpiration, Water Use and Cannabinoid Contents in Field Grown Drug Type Varieties of Cannabis sativa L (abst–2011) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0031-1273536
Study on spectral reflectance characteristics of hemp canopies (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21322234
Factors determining yield and quality of illicit indoor cannabis (Cannabis spp)  production (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21737218
The Effect of Electrical Lighting Power and Irradiance on Indoor-Grown Cannabis Potency and Yield (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211717
Cadmium Tolerance and Bioaccumulation of 18 Hemp Accessions (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21938417
Molecular analysis of genetic fidelity in Cannabis sativa L. plants grown from synthetic (encapsulated) seeds following in vitro storage (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21805186
Small-scale cannabis growers in Denmark and Finland (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21325852
Investigations into the Hypothesis of Transgenic Cannabis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211569
Genetic Identification of Female Cannabis sativa Plants at Early Developmental Stage (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1249978
Molecular Analysis of Genetic Stability in Synthetic Seeds Grown Cannabis sativa L Plants (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273531
Biotechnology of Cannabis sativa L. (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273535
Variations in Photosynthesis, Transpiration, Water Use and Cannabinoid Contents in Field Grown Drug Type Varieties of Cannabis sativa L (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273536
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L under Slow Growth Conditions (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273532
Analysis of Genetic Diversity using SSR Markers and Cannabinoid Contents in Different Varieties of Cannabis sativa L (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273534
Botany of Cannabis sativa L.: Identification, Cultivation and Processing  (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273533
EVALUATION ALLELOPATHIC EFFECT OF HEMP (CANNABIS SATIVA L.) ON GERMINATION AND GROWTH OF THREE KINDS OF WEEDS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=246119
top

Characteristics of cannabinoids composition of Cannabis plants grown in Northern
Thailand and its forensic application (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21636228
What Medical Marijuana strain is best for your condition, Sativa or Indica? (forum repost – 2011) https://www.420magazine.com/forums/medical-marijuana-lounge/144632-what-medical-marijuana-strainbest-your-condition-sativa-indica.html
Cannabis sativa – An Important Subsistence Pollen Source for Apis mellifera (full–2012) http://iosrjournals.org/iosr-jpbs/papers/vol1-issue4/A0140103.pdf
Cannabis – from cultivar to chemovar (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22362625
Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis
Cuttings and Seedlings During Growth of Plants (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22390363
Why small-scale cannabis growers stay small: Five mechanisms that prevent small-scale
growers from going large scale (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/23036648
Yield and turnover of illicit indoor cannabis (Cannabis spp.) plantations in Belgium  (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22502940
Studies on the Optimization of Agrotechniques to Maximize the Productivity of Two  Cannabis Chemotypes Cultivated to Produce Medicinal Grade Plant Material (abst–2012) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0032-1307524
Biomass Yield Studies of Field Cultivated Cannabis sativa L. Plants (abst–2012)  https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1307513
Propagating Medicinal Plants Under Good Agricultural Practices (GAP): Cannabis sativa
L. – A Case Study (abst–2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1307514
THE EFFECTS OF JAMONATE ON PLASTIDAL TERPENOIDS ON CANNABIS SATIVA L. AT VEGETATIVE STAGE (abst–2012) http://en.journals.sid.ir/ViewPaper.aspx?ID=305238
Temperature and Moisture Content for Storage Maintenance of Germination Capacity of
Seeds of Industrial Hemp, Marijuana, and Ditchweed Forms of Cannabis sativa (abst–2012) http://www.tandfonline.com/doi/abs/10.1080/15440478.2012.737179?needAccess=true&journalCode=wjnf20
The role of child protection in cannabis grow-operations (full–2013) http://www.canorml.org/child.welfare.pdf
Ethephon application stimulates cannabinoids and plastidic terpenoids production in
Cannabis sativa at flowering stage (link to PDF–2013)  https://www.researchgate.net/publication/236108070_Ethephon_application_stimulats_cannabinoids_and_plastidic_terpenoids_production_in_Cannabis_sativa_at_flowering_stage
Nematicidal activities of Cannabis sativa L. and Zanthoxylum alatum Roxb. against Meloidogyne incognita (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0926669012003494
A review of the cultivation and processing of cannabis (Cannabis sativa L) for production of prescription medicines in the UK (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1531/full
Ecophysiological Aspects of in vitro Propagated Cannabis sativa L. Plants During Acclimatization (abst–2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1336455
THE EFFECT OF ABA ON PIGMENTS AND TETRAHYDROCANNABINOL IN CANNABIS SATIVA AT FLOWERING STAGE (abst–2013) http://en.journals.sid.ir/ViewPaper.aspx?ID=351874
Potential exposures associated with indoor marijuana growing operations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24116667
Analysis of the NMI01 marker for a population database of cannabis seeds (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23216136
Recommendations for Regulators – Cannabis Operations (full–2014) http://tinyurl.com/zfdz6g7
Let it grow—the open market solution to marijuana control (full–2014) http://www.harmreductionjournal.com/content/11/1/32
Study of leaf metabolome modifications induced by UV-C radiations in representative Vitis, Cissus and Cannabis species by LC-MS based metabolomics and antioxidant assays (full–2014) http://www.mdpi.com/1420-3049/19/9/14004/htm
Hashish revival in Morocco (full–2014) http://www.ijdp.org/article/S0955-3959%2814%2900003-6/fulltext
Molecular cytogenetic characterization of the dioecious Cannabis sativa with an XY chromosome sex determination system (full–2014) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085118
Influence of mevinolin on chloroplast terpenoids in Cannabis sativa (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988329/
N-Acylethanolamines: lipid metabolites with functions in plant growth and development (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/tpj.12427/full
New evidence on the introduction, cultivation and processing of hemp (Cannabis sativa L.) in southern Sweden (link to download–2014) http://www.academia.edu/11727026/New_evidence_on_the_introduction_cultivation_and_processing_of_h emp_Cannabis_sativa_L._
Amber is Bad ? (article – 2014) http://growhappyplants.com/look.html
Induction of male flowers on female plants of Cannabis sativa by gibberellins and its inhibition by abscisic acid (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24477812
top

Growing medicine: Small-scale cannabis cultivation for medical purposes in six different countries (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123694
Cannabis, Pesticides and Conflicting Laws: the Dilemma for Legalized States and Implications for Public Health (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24859075
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24934168
Effective Phytoextraction of Cadmium (Cd) with Increasing Concentration of Total Phenolics and Free Proline in Cannabis sativa (L) Plant Under Various Treatments of Fertilizers, Plant Growth Regulators and Sodium Salt (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25174425
Attitudes of cannabis growers to regulation of cannabis cultivation under a nonprohibition cannabis model (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25181993
Production, perceptions, and punishment: Restrictive deterrence in the context of cannabis cultivation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25223245
Cold acclimation induces distinctive changes in the chromatin state and transcript levels of COR genes in Cannabis sativa varieties with contrasting cold acclimation capacities (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25534661
Cannabis micropropagation – Applications and updates (abst–2014) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1382549
EFFECT OF BIOFERTILIZER, UNDER SALINITY CONDITION ON THE YIELD AND OIL CONTENT OF THREE ECOTYPE OF HEMP (CANNABIS SATIVA L.) (abst–2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=461808
Allelopathic effect of fibre hemp (Cannabis sativa L.) on monocot and dicot plant species (abst–2014) http://www.sciencedirect.com/science/article/pii/S092666901400106X
How to Use Dr. Bronners As Insecticidal Soap (news-2014) http://www.ehow.com/how_5791479_use-dr_-bronners-insecticidal-soap.html
Powdery Mildew On Marijuana Plants (news–2014) http://www.ilovegrowingmarijuana.com/marijuana-diseases-powdery-mildew/
Music to grow cannabis by (news–2014) http://www.stuff.co.nz/national/crime/9637421/Music-to-grow-cannabis-by
Hemp growers cooperatives’ report touts crop’s benefits to coal (news–2014) http://www.kentucky.com/news/business/article44465766.html#
Weed’s Chronic Energy Use Becomes a Concern (news–2014) http://www.technologyreview.com/news/528646/weeds-chronic-energy-use-becomes-a-concern/
Mississippi, home to federal government’s official stash of marijuana (news–2014) http://www.latimes.com/nation/la-na-pot-monopoly-20140529-story.html
Before pot yield of their dreams, constant care for fickle plants (news–2014) http://seattletimes.com/html/localnews/2023950678_potseries2xml.html?syndication=rss
Why Chocolope? To sell marijuana, you need a clever name (news–2014) http://www.latimes.com/business/la-fi-marijuana-names-20140711-story.html#page=1
What Makes Cannabis Purple? (news–2014) http://sensiseeds.com/en/blog/what-makes-cannabis-purple/
Thomas Jefferson’s Favorite Plant Is Back in American Soil (news-2014) http://www.huffingtonpost.com/doug-fine/thomas-jeffersons-favorit_b_5582029.html? ncid=txtlnkusaolp00000592
Federal marijuana bill would legalize some cannabis strains (news–2014) http://www.cnn.com/2014/07/28/health/federal-marijuana-bill/index.html
U.S. government to grow 30 times more marijuana this year (news–2014) http://www.latimes.com/science/sciencenow/la-sci-sn-government-marijuana-20140827-story.html
Marijuana: Italian Army to Grow Cannabis for Medical Purposes (news–2014) https://uk.news.yahoo.com/marijuana-italian-army-grow-cannabis-medical-purposes- 120852716.html#oZ9vNGz
Where Americans Smoke and Grow Marijuana (Maps) (news–2014) http://www.livescience.com/48606-marijuana-maps-of-united-states.html
Legal Pot In The U.S. May Be Undercutting Mexican Marijuana (news–2014) http://www.npr.org/blogs/parallels/2014/12/01/367802425/legal-pot-in-the-u-s-may-be-undercuttingmexican-marijuana?utm_medium=RSS&utm_campaign=storiesfromnpr
U.S. won’t stop Native Americans from growing, selling pot on their lands (news–2014) http://www.latimes.com/business/la-fi-marijuana-indians-20141211-story.html
Money to burn (news – 2014) http://mashable.com/2014/12/31/marijuana-farm-startup/?utm_campaign=Mash-Prod-RSS-Feedburner-AllPartial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial&utm_medium=feed&utm_source=rss
What is the difference between Indica and Sativa Marijuana Plants? (news-2014) http://www.theweedblog.com/the-difference-between-indica-and-sativa-marijuana-plants/ Flowering Week by Week (news–2014) http://www.bloomwellbend.com/flowering-week-week/
Why Don’t We Grow Tomatoes in Basements? The Future of Cannabis Cultivation Is in Greenhouses (news–2014) http://www.leafscience.com/2014/07/09/dont-grow-tomatoes-basements-future-cannabis-cultivationgreenhouses/?utm_source=mantis&utm_medium=recommend&utm_campaign=mantis
Effect of Induced Polyploidy on Some Biochemical Parameters in Cannabis sativa L (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25492688
The globalisation of cannabis cultivation: A growing challenge (full–2015) http://www.ijdp.org/article/S0955-3959%2815%2900003-1/fulltext
Intrusive growth of primary and secondary phloem fibres in hemp stem determines fibre bundle formation and structure (full–2015) http://aobpla.oxfordjournals.org/content/early/2015/05/27/aobpla.plv061.long
Global patterns of domestic cannabis cultivation: Sample characteristics and patterns of growing across eleven countries (full–2015) http://www.ijdp.org/article/S0955-3959%2814%2900363-6/fulltext
The Genetic Structure of Marijuana and Hemp (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0133292
Comparative genomics of a cannabis pathogen reveals insight into the evolution of pathogenicity in Xanthomonas (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468381/
Impacts of surface water diversions for marijuana cultivation on aquatic habitat in four northwestern California watersheds (full–2015)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120016
The globalisation of cannabis cultivation: A growing challenge (full–2015) http://www.ijdp.org/article/S0955-3959%2815%2900003-1/fulltext
Are Moroccan cannabis growers able to adapt to recent European market trend? (full–2015) http://www.ijdp.org/article/S0955-3959%2814%2900336-3/fulltext
Cannabinoids Production by Hairy Root Cultures of Cannabis sativa L. (full–2015) http://file.scirp.org/Html/21-2601738_58491.htm
Seized cannabis seeds cultivated in greenhouse: A chemical study by gas chromatography–mass spectrometry and chemometric analysis (full–2015)
http://www.scienceandjusticejournal.com/article/S1355-0306%2815%2900111-2/fulltext
CONTROLLED SUBSTANCES CHAOS: THE DEPARTMENT OF JUSTICE’S NEW POLICY POSITION ON MARIJUANA AND WHAT IT MEANS FOR INDUSTRIAL HEMP FARMING IN NORTH DAKOTA (link to download – 2015) https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwiM06KU38jRAhVX02MKHUFDCoUQFggbMAA&url=https%3A%2F%2Flaw.und.edu%2F_files%2Fdocs%2Fndlr%2Fpdf%2Fissues%2F90%2F3%2F90ndlr599.pdf&usg=AFQjCNG6NzffFzGQ7-_Ok6Zm11G52HOBgg&bvm=bv.144224172,d.cGc
Potency 101 (printable card set–2015) http://greenstyleconsulting.com/potency-101/
Assessing the harms of cannabis cultivation in Belgium (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25599596
top

Cannabis cultivation in Quebec: Between space-time hotspots and coldspots (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25620750
“Should I Buy or Should I Grow?” How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655217
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25492688
Evaluation of elemental profiling methods, including laser-induced breakdown spectroscopy (LIBS), for the differentiation of Cannabis plant material grown in different nutrient solutions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25898182
In Vitro Propagation of Cannabis sativa L. Using meta-Topolin (abst-2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1545167
Legal issues for German-speaking cannabis growers. Results from an online survey (abst–2015) http://www.ijdp.org/article/S0955-3959%2815%2900315-1/abstract
Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana) (abst–2015) http://link.springer.com/article/10.1007/s10722-015-0254-2
Molecular cytogenetic analysis of monoecious hemp (Cannabis sativa L) cultivars reveals its karyotype variations and sex chromosomes constitution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26149370
Expansion of female sex organs in response to prolonged virginity in Cannabis sativa (marijuana)  (abst–2015) http://www.agr.gc.ca/eng/abstract/?id=35387000000564
Tyler Markwart: The Case For GMO Cannabis (interview–2015) http://www.ganjapreneur.com/tyler-markwart-gmo-marijuana/
Cannabis sativa: The Plant of the Thousand and One Molecules (full–2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00019/full
High Time for Conservation: Adding the Environment to the Debate on Marijuana Liberalization (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776720/
Studying Secondary Growth and Bast Fiber Development: The Hemp Hypocotyl Peeks behind the Wall (full–2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.01733/full
A Belated Green Revolution for Cannabis: Virtual Genetic Resources to Fast-Track Cultivar Development (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965456/
Monitoring Metabolite Profiles of Cannabis sativa L. Trichomes during Flowering Period
Using 1H NMR-Based Metabolomics and Real-Time PCR (full–2016) https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0042-108058
Transcriptome differences between fiber-type and seed-type Cannabis sativa variety
exposed to salinity (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120038/
Abnormal Meiosis in Tetraploid (4x) Cannabis sativa from Lahaul-spiti (Cold Desert
High Altitude Himalayas)-A Neglected But Important Herb (download–2016)  http://www.eresearchco.com/jbcc-pdf/6%20VKS%20JBCC%202_1_.pdf
Applications To Become Registered Under the Controlled Substances Act To Manufacture Marijuana To Supply Researchers in the United States. Policy statement. (click “Link out” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529905
DEA Announces Actions Related to Marijuana and Industrial Hemp (article–2016)  https://www.dea.gov/divisions/hq/2016/hq081116.shtml
Farming medical ganja in Jamaica (click ELSEVIER for 1st page–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27296757
Hashish in Morocco and Lebanon: A comparative study (abst–2016) http://www.ijdp.org/article/S0955-3959(16)30056-1/abstract
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Chapter 1 – The Botany of Cannabis sativa L (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000011
Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jnatprod.5b00949
The influences of cultivation setting on inflorescence lipid distributions, concentrations, and carbon isotope ratios of Cannabis sp. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27045381
In Vitro Propagation of Cannabis sativa L. and Evaluation of Regenerated Plants for Genetic Fidelity and Cannabinoids Content for Quality Assurance (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27108324
Phytotoxic Effect of Fiber Hemp Essential Oil on Germination of Some Weeds and Crops (abst–2016) http://www.tandfonline.com/doi/abs/10.1080/0972060X.2015.1137236? journalCode=teop20
Use of Embryos Extracted from Individual Cannabis sativa Seeds for Genetic Studies and Forensic Applications (abs  2016) http://www.ncbi.nlm.nih.gov/pubmed/27404624 Cannabis clubs in Uruguay: The challenges of regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475713
Cannabis cultivation in Spain: A profile of plantations, growers and production systems (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27619556
Near infrared spectroscopy combined with chemometrics for growth stage classification of cannabis cultivated in a greenhouse from seized seeds (abst–2016) http://www.sciencedirect.com/science/article/pii/S1386142516305583
Understanding and learning from the diversification of cannabis supply laws (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891693
Estimating the production, consumption and export of cannabis: The Dutch case (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27048853
High Time to Assess the Environmental Impacts of Cannabis Cultivation (full–2017) http://pubs.acs.org/doi/full/10.1021/acs.est.6b06343
Challenges towards Revitalizing Hemp: A Multifaceted Crop (full–2017)  http://www.cell.com/trends/plant-science/fulltext/S1360-1385(17)30177-2
Endogenous synthesis of pyrethrins by cannabis (not all strains, just medihaze, so far)  (link to PDF-2017) http://www.biorxiv.org/content/early/2017/07/28/169417
A new neglected crop: cannabis (summary–full is free with registration-2017)  http://science.sciencemag.org/content/356/6335/232
Pesticide Use on Cannabis (link to article–2017)  https://www.technologynetworks.com/tn/white-papers/pesticide-use-on-cannabis-288143
Uruguay’s middle-ground approach to cannabis legalization (1st page–2017)  http://www.ijdp.org/article/S0955-3959(17)30055-5/fulltext
Cannabis cultivation: Methodological issues for obtaining medical-grade product (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30588-1/fulltext
Cannabis cultivation within a religious context: A case study of Ghomara in the Rif
Mountain (Northern Morocco) (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28375809
Support for marijuana legalization in the US state of Washington has continued to
increase through 2016 (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30171-0/fulltext
Why is it so difficult to determine the yield of indoor cannabis plantations? A case study
from the Netherlands (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28502714
The use of pesticides in Belgian illicit indoor cannabis plantations (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0379073817301871
U.S. cannabis legalization and use of vaping and edible products among youth (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30184-9/fulltext
Molecular characterization, vector identification and sources of phytoplasmas associated
with brinjal little leaf disease in India (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28391472
Optimal Rate of Organic Fertilizer during the Vegetative-stage for Cannabis Grown in
Two Coir-based Substrates (abst–2017)  http://hortsci.ashspublications.org/content/52/9/1307.abstract?sid=bfe42f6d-f2ae-42d8-8291-c13f8a327d67
Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing
relationship? (abst–2017) http://www.ijdp.org/article/S0955-3959(17)30292-X/fulltext
Pharmacological Foundations of Cannabis Chemovars (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29161743
Into the void: Regulating pesticide use in Colorado’s commercial cannabis markets (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28173984
Community-level policy responses to state marijuana legalization in Washington State  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28365192
The application of plant in vitro cultures in cannabinoid production (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29249063
Regulating Hemp and Cannabis-Based Products (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29095577
The three betrayals of the medical cannabis growing activist: From multiple victimhood
to reconstruction, redemption and activism (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29287224
Grass is not always greener: rodenticide exposure of a threatened species near marijuana growing operations (full–2018)  https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-018-3206-z
Microbial hazards during harvesting and processing at an outdoor United States cannabis farm (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29370578


CUSHING’S SYNDROME
CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23884964


CYSTIC FIBROSIS*+
“Bong lung” in cystic fibrosis: a case report (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998526/?toolmcentrez
Treatment with tetrahydrocannabinol (THC) prevents infertility in male cystic fibrosis mice (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22865360
Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy (abst–2011) http://www.degruyter.com/abstract/j/jbcpp.2011.22.issue-1-2/jbcpp.2011.005/jbcpp.2011.005.xml?rskey=wRYgJd&result=2&q=cannabinoid


CYSTITIS +
The afferent system and its role in lower urinary tract dysfunction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21537194
Activation of Cannabinoid Receptor 2 Inhibits Experimental Cystitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652164/
Treatment with a Cannabinoid Receptor 2 Agonist Decreases Severity of Established Cystitis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24184363
Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355044/
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24561047
top

Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25463999
Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446380/
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408170


Advertisements